Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E16.32 EPS (ttm)10.26 Insider Own0.10% Shs Outstand736.45M Perf Week-8.30%
Market Cap123.32B Forward P/E13.13 EPS next Y12.75 Insider Trans0.00% Shs Float735.42M Perf Month-3.29%
Income7.72B PEG2.55 EPS next Q3.00 Inst Own80.50% Short Float1.19% Perf Quarter14.12%
Sales22.99B P/S5.36 EPS this Y13.10% Inst Trans-1.79% Short Ratio2.24 Perf Half Y-2.10%
Book/sh40.59 P/B4.13 EPS next Y3.56% ROA10.10% Target Price186.07 Perf Year14.10%
Cash/sh51.71 P/C3.24 EPS next 5Y6.41% ROE25.90% 52W Range131.83 - 184.21 Perf YTD15.32%
Dividend4.60 P/FCF18.92 EPS past 5Y20.50% ROI13.00% 52W High-9.07% Beta1.25
Dividend %2.75% Quick Ratio3.90 Sales past 5Y8.10% Gross Margin81.90% 52W Low27.05% ATR3.31
Employees19200 Current Ratio4.10 Sales Q/Q7.70% Oper. Margin42.60% RSI (14)41.81 Volatility1.96% 1.54%
OptionableYes Debt/Eq1.16 EPS Q/Q10.50% Profit Margin33.60% Rel Volume0.91 Prev Close167.45
ShortableYes LT Debt/Eq1.01 EarningsFeb 02 AMC Payout38.70% Avg Volume3.93M Price167.50
Recom2.30 SMA20-5.07% SMA500.28% SMA2005.24% Volume1,507,181 Change0.03%
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-20-16Initiated Credit Suisse Outperform $205
Dec-15-15Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-04-15Initiated Wells Fargo Market Perform
Oct-29-15Reiterated UBS Buy $168 → $180
Sep-01-15Initiated Raymond James Mkt Perform
Jul-31-15Reiterated RBC Capital Mkts Outperform $185 → $190
Jul-31-15Reiterated Deutsche Bank Buy $192 → $195
Jul-31-15Reiterated Barclays Equal Weight $180 → $185
May-28-15Reiterated Deutsche Bank Buy $200 → $192
Apr-22-15Reiterated UBS Buy $175 → $185
Apr-22-15Reiterated RBC Capital Mkts Outperform $178 → $185
Mar-23-17 10:57AM  Biotechs Back in the Doghouse After Failed Rally at Investopedia
09:00AM  How This Company Is Taking on Amgen at Motley Fool
Mar-22-17 03:21PM  Biotech giant plans $25M Tampa investment, 450 jobs at bizjournals.com
11:25AM  Health ETF Wobbles As Vote On Bill To Replace ObamaCare Nears; Gold Gains
09:30AM  Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
08:33AM  Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar-21-17 04:54PM  Sanofi and Regeneron Sue Amgen over Eczema Drug at Investopedia
02:45PM  Sanofi-Genzyme files preemptive legal strike to protect eczema drug at bizjournals.com
12:49PM  4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
12:33PM  Sanofi, Regeneron sue Amgen to protect eczema drug from patent claims
11:00AM  ONCYF: Oncolytic Viruses Emerging as Effective Cancer Treatment
09:25AM  3 Biotech Stocks That Are Broker Favorites
Mar-20-17 08:08PM  Esperion Therapeutics Inc (ESPR): Get It While Its Cheap at Insider Monkey
05:02PM  Here's What Pushed Esperion Therapeutics Inc Stock Higher Today at Motley Fool
04:09PM  Esperion And Medicines Co. Recover From Amgen-Induced Pitfall
01:18PM  Why Amgen's Success Was a Big Disappointment at Motley Fool
10:26AM  Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop
10:22AM  Trump, Biogen and Amgen Hammer Healthcare ETFs
10:06AM  Why Biotech Stock Gilead (GILD) Could Be a Value Trap
09:40AM  There's a Middle Ground in Amgen's Drug-Price Battle
07:32AM  Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug at Forbes
04:55AM  Lowering LDL Levels with Repatha(R) (evolocumab) Did Not Adversely Affect Cognitive Function in Landmark Phase 3 Study PR Newswire
03:28AM  Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues PR Newswire
01:00AM  Slow Day for the Market; Adobe Builds Next Step in Tech Surge: Jim Cramer's View
Mar-19-17 02:00PM  Analyses Of PCSK9 Inhibitor Prescription Rejection Rates Demonstrate Significant Access Barriers For Appropriate Patients PR Newswire
11:01AM  Is Trump Bad for Healthcare Stocks? These 4 Winners Don't Think So at Motley Fool
Mar-18-17 08:00AM  Lowering LDL Levels With Repatha® (Evolocumab) Did Not Adversely Affect Cognitive Function In Landmark Phase 3 Study PR Newswire
Mar-17-17 11:47PM  Amgens Repatha Study Shows Reduced Risk of Heart Attack, Stroke at The Wall Street Journal -6.38%
11:43PM  [$$] Amgens Money-Back Guarantee at The Wall Street Journal
07:18PM  Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke at The Wall Street Journal
07:15PM  How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More
05:44PM  Week in Review: Stocks Post Small Gains After Fed Pulls Trigger on Third Hike Since Crisis
04:59PM  The Biggest Loser: Amgen Drops 6.4% at Barrons.com
04:50PM  Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing
04:49PM  Amgen discounts cholesterol drug, but payers want more
04:30PM  Why Amgen, AmTrust Financial Services, and BRF Slumped Today at Motley Fool
04:28PM  Amgen Tanks On Heart Study; Shares Of Other Drugmakers Tumble
04:19PM  Markets Right Now: Early gain for stocks fades at close
04:07PM  New cholesterol-fighting drug slashes heart attack risk, but at a steep price; Amgen shares drop at CNBC
04:03PM  Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report
02:56PM  Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks? at Insider Monkey
02:22PM  Nasdaq Hits Record High As Stocks Slowly Gain Steam
01:51PM  [$$] Amgen's Money-Back Guarantee at The Wall Street Journal
01:32PM  Stocks Turn Higher Even as Amgen Leads Another Health Care Selloff
01:18PM  Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today at Motley Fool
01:03PM  CVS Health says Amgen data may increase eligible patients by millions
01:03PM  Amgen Blew ItFor Medicines Co., Esperion Too at Barrons.com
01:00PM  Amgen's Repatha Reduced Heart Attack, Stroke Risk at Investopedia
12:52PM  US STOCKS-Wall St flat as tech gains offset weakness in banks
12:46PM  Why Amgen's Getting Crushed at Barrons.com
12:40PM  Be Patient With Amgen After Its Major Breakdown
12:04PM  Midday Report: Amgen Leads Health Care Lower; U.S. Stocks Fall at TheStreet
11:46AM  GLOBAL MARKETS-World stocks hover near peaks, dollar extends slide Reuters
11:38AM  US STOCKS-Wall St edges lower as financial stocks drag
11:22AM  Express Scripts says Amgen data opens door to patients
11:03AM  [video]AveXis, Esperion and Amgen Among Biotech Movers
10:38AM  Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate
10:37AM  This Key Measure Shows the S&P Could Be Headed for a 5% Pullback
10:09AM  US stocks mixed, still on pace for yet another winning week
10:04AM  US STOCKS-Wall St little changed as healthcare stocks weigh
09:33AM  5 Biotech Companies To Watch In 2017
09:00AM  Landmark Outcomes Study Shows That Repatha® (Evolocumab) Decreases LDL-C To Unprecedented Low Levels And Reduces Risk Of Cardiovascular Events With No New Safety Issues PR Newswire
09:00AM  Amgen cholesterol drug cuts heart attack, stroke risk more than 20 pct-study
08:48AM  What are Sanofi's (SNY) Strengths and Challenges in 2017?
Mar-16-17 05:52PM  Billion dollar boost for Amgen?
04:09PM  Markets Right Now: US indexes waver to mixed close
02:30PM  5 Biotech Companies Set for Major Breakouts In 2017
10:49AM  Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China
10:00AM  Does Amgen Offer a Great Value Buying Opportunity Right Now?
08:46AM  Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data
08:05AM  Life-Saving Device Could Transform The Medical Market In 2017
Mar-15-17 07:01PM  Cramer: The Airlines and Health-Care Names Are Really Soaring
11:48AM  Jim Cramer: Amgen's Pipeline Positions It Well to Withstand a Rate Hike
09:55AM  Cramer's Stop Trading: Amgen's pipeline
Mar-14-17 04:15PM  Repatha® (Evolocumab) Four-Year Open-Label Follow-Up Study Published In 'JAMA Cardiology' PR Newswire
04:06PM  Amgen Could Boost Rivals On Positive Heart-Disease Study: Analyst
04:00PM  Amgen To Webcast Investor Meeting At Upcoming American College Of Cardiology Scientific Sessions PR Newswire
10:35AM  Amgen's Repatha Meets Primary Endpoint in Phase III Study
Mar-13-17 04:37PM  Amgen Tops Heart Study As Rivals Regeneron, Sanofi Chill In Court
09:24AM  Amgen's Repatha lowers need for cholesterol-lowering procedure
09:20AM  Amgen says its Repatha reduced need for high cholesterol therapy in late-stage clinical trial at MarketWatch
09:00AM  Repatha® (Evolocumab) Demonstrates Reduced Need For Apheresis In Patients With High LDL Cholesterol In Phase 3 Study PR Newswire
08:00AM  Early movers: MBLY, INTC, YHOO, BA, IT, NAV, DISH, F, AMGN & more at CNBC
01:00AM  Data on heart benefits of Amgen drug is key to unlocking sales
Mar-11-17 11:41AM  Which Biotech Is the Best Dividend Stock? at Motley Fool
Mar-10-17 07:27PM  World economy stronger than you think
06:53PM  Cramer's game plan: The world economy is stronger than yo...
06:15PM  Cramer's game plan: The world economy is stronger than you think this stock will prove it at CNBC
04:39PM  Under-The-Radar Biotech Tests Buy Zone; Cancer Trial Results 'Encouraging'
01:12PM  AbbVie Stock Upgraded: What You Need to Know at Motley Fool
10:30AM  Major Biotechs See a Retreat in Short Interest
09:28AM  Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?
Mar-09-17 04:31PM  Momo Dives Despite Price Target Hike; UBS Initiates Biotechs; Mercury Is A Buy
03:52PM  Pro: Opportunitiy if you can get beyond overall market an...
10:01AM  Coverage initiated on Amgen by UBS
09:21AM  AbbVie at the Cowen Healthcare Conference: 4 Things You'll Want to Know at Motley Fool
Mar-08-17 04:47PM  Pharma says high prices fund drug development but this study finds otherwise at MarketWatch
09:30AM  J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day
08:35AM  State Street Calls for More Women on Boards
Mar-07-17 07:01PM  Cramer: When a Trump Tweet Is a Buy Signal
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for the prevention of skeletal-related events; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Erenumab for the prevention of chronic migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; AMJEVITA to treat psoriatic arthritis and polyarticular juvenile idiopathic arthritis, as well as ankylosing spondylitis and moderate-to-severe rheumatoid arthritis; ABP 215 for biosimilar candidates; and ABP 980 to treat human epidermal growth factor receptor 2-positive early breast cancer. The company's other marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products for use to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
de Carbonnel FrancoisDirectorSep 09Option Exercise71.645,000358,20021,171Sep 13 06:21 PM
Such Annette LouiseVP, Finance and CAOAug 02Sale174.593,000523,7587,183Aug 03 08:14 PM
Balachandran MadhavanEVP, OperationsMay 04Sale154.1230,0004,623,62455,996May 05 08:16 PM
BALTIMORE DAVIDDirectorApr 29Sale157.213,312520,68432,350May 03 07:12 PM
BALTIMORE DAVIDDirectorMar 30Option Exercise50.445,000252,20037,350Mar 31 06:01 PM
UNP Union Pacific Corporation daily Stock Chart
UNP [NYSE]
Union Pacific Corporation
IndexS&P 500 P/E20.52 EPS (ttm)5.07 Insider Own0.20% Shs Outstand813.80M Perf Week-1.44%
Market Cap84.68B Forward P/E16.42 EPS next Y6.34 Insider Trans-3.11% Shs Float812.98M Perf Month-4.57%
Income4.23B PEG1.81 EPS next Q1.25 Inst Own81.20% Short Float1.23% Perf Quarter1.21%
Sales19.94B P/S4.25 EPS this Y-7.70% Inst Trans-0.68% Short Ratio2.61 Perf Half Y13.03%
Book/sh24.33 P/B4.28 EPS next Y12.66% ROA7.60% Target Price113.21 Perf Year29.90%
Cash/sh1.64 P/C63.34 EPS next 5Y11.34% ROE20.90% 52W Range75.45 - 110.75 Perf YTD0.94%
Dividend2.42 P/FCF39.55 EPS past 5Y8.60% ROI13.60% 52W High-5.52% Beta0.77
Dividend %2.33% Quick Ratio0.80 Sales past 5Y0.40% Gross Margin81.20% 52W Low38.69% ATR1.57
Employees42919 Current Ratio1.00 Sales Q/Q-0.80% Oper. Margin36.50% RSI (14)41.02 Volatility1.36% 1.48%
OptionableYes Debt/Eq0.75 EPS Q/Q6.30% Profit Margin21.20% Rel Volume0.53 Prev Close104.06
ShortableYes LT Debt/Eq0.71 EarningsApr 20 BMO Payout43.20% Avg Volume3.84M Price104.64
Recom2.40 SMA20-1.98% SMA50-2.09% SMA2007.70% Volume857,893 Change0.56%
Mar-14-17Initiated Wells Fargo Market Perform
Jan-20-17Reiterated RBC Capital Mkts Sector Perform $111 → $115
Jan-20-17Reiterated Cowen Market Perform $98 → $109
Jan-18-17Initiated Buckingham Research Neutral
Jan-09-17Upgrade Barclays Equal Weight → Overweight $104 → $122
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-24-16Initiated Seaport Global Securities Buy $100
Oct-21-16Downgrade RBC Capital Mkts Outperform → Sector Perform $107 → $98
Oct-20-16Downgrade Cowen Outperform → Market Perform $99 → $91
Jul-20-16Downgrade Deutsche Bank Buy → Hold $94
Jun-03-16Upgrade Morgan Stanley Equal-Weight → Overweight $90
May-19-16Initiated Credit Agricole Sell
Apr-22-16Reiterated RBC Capital Mkts Outperform $90 → $95
Apr-18-16Downgrade UBS Buy → Neutral $89 → $88
Feb-23-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-22-16Upgrade BofA/Merrill Neutral → Buy
Jan-25-16Reiterated Argus Buy $110 → $80
Jan-22-16Reiterated Stifel Buy $95 → $78
Jan-22-16Reiterated RBC Capital Mkts Outperform $93 → $82
Jan-22-16Reiterated Deutsche Bank Buy $93 → $87
Mar-23-17 09:05AM  How Did GWRs North American Carloads Trend in February 2017?
07:36AM  Did Coal Push Up Canadian Pacifics Carloads in the 10th Week?
Mar-22-17 05:10PM  Winter Park Express ski train's success may mean changes next year (Video) at bizjournals.com
07:36AM  BNSF Railway Saw Growth in Carloads Volume
Mar-21-17 10:37AM  How Did Union Pacifics Intermodal Volumes Fare?
09:07AM  How Union Pacifics Carloads Compare to BNSF Railways
07:37AM  How Norfolk Southerns Carloads Stacked Up against Peers
Mar-20-17 03:15PM  Union Pacific Implores Photographers: Do Not Take Pictures On or Near Railroad Tracks #photosafety PR Newswire
Mar-17-17 09:00AM  Union Pacific Announces Annual Payments of Interest on Certain Bonds and Debentures PR Newswire
07:36AM  Analyzing Canadian Pacifics Carloads in the 9th Week
Mar-16-17 07:01AM  Coal isn't dead yet and the railroads are loving it
Mar-15-17 11:02AM  Union Pacific Could Track Sharply Lower
10:38AM  How Did Union Pacifics Intermodal Volumes Fare Last Week?
09:15AM  For an Inflation Hedge, Jump Aboard This Railroad Monopoly
09:06AM  Did Coal Boost Union Pacifics Carloads?
07:37AM  These Commodities Boosted Norfolk Southerns Carloads
Mar-14-17 03:35PM  Northeast storm hits transport stocks
10:01AM  Mosier derailment, fire recalled as Legislature takes up oil-train regulations at bizjournals.com
06:12AM  Coverage initiated on Union Pacific by Wells Fargo
Mar-13-17 06:00AM  An Ideal Investment for Long-Term Investors at Morningstar
Mar-10-17 07:07PM  Official: Fire still burning hours after Iowa derailment
11:36AM  The Latest: Company: Train with ethanol in fiery derailment
Mar-09-17 10:31AM  Federal court dismisses Union Pacific's lawsuit in Gorge track expansion dispute at bizjournals.com
Mar-08-17 11:04AM  UNION PACIFIC CORP Files SEC form 8-K, Regulation FD Disclosure
07:36AM  Unloading Canadian Pacifics Latest Carloads
Mar-07-17 11:02AM  [$$] Miss the CSX Rally? Try Norfolk Southern at Barrons.com
10:36AM  Your Guide to BNSF Railways Latest Carload Data
09:07AM  A Birds Eye View of CSXs Intermodal Volumes in the 8th Week
Mar-06-17 04:05PM  These Commodity Groups Boosted Union Pacifics Carloads Last Week
02:35PM  Where Norfolk Southerns Carloads Stand in the Industry Now
12:45PM  Unpacking Union Pacifics Intermodal Volumes
Mar-03-17 01:13PM  Caltrain's firing of safety project contractor not expected to further slow completion at bizjournals.com
07:37AM  Is Berkshires BNSF Finally on the Fast Track?
Mar-01-17 09:30AM  Union Pacific Corporation CFO Rob Knight to Address the Raymond James 38th Annual Institutional Investors Conference PR Newswire
Feb-28-17 10:37AM  Looking at CSXs Intermodal Volumes in the 7th Week of 2017
09:08AM  Comparing Canadian Pacifics Carloads
09:08AM  How Union Pacifics Intermodal Volumes Fared
07:38AM  Comparing Union Pacifics Carloads
Feb-27-17 05:35PM  Which Commodity Groups Boosted Norfolk Southerns Carloads?
03:05PM  Will Hunter Harrisons Entry Be a New Dawn at CSX?
Feb-23-17 03:28PM  Union Pacific Police Pursues Prestigious CALEA Accreditation PR Newswire
09:05AM  How Canadian Pacifics Stand up to Rival Canadian National
Feb-22-17 09:06AM  These Commodity Groups Pushed BNSF Railways Carloads
07:36AM  The Story behind Union Pacifics Intermodal Volumes
04:21AM  Union Pacific (UNP) Up 3.4% Since Earnings Report: Can It Continue?
Feb-21-17 04:58PM  Expeditors (EXPD) Beats on Q4 Earnings, Revenues
03:35PM  Union Pacifics Carloads Are Facing These Growth Limits
02:06PM  How Higher Coal Volumes Are Lifting Up Norfolk Southern
12:45PM  Unusual Activity: Bulls target PBI & UNP
Feb-20-17 08:01AM  5 Trade Ideas for Tuesday: Commerce Bancshares, Cirrus Logic, McCormick, Ulta Beauty and Union Pacific
Feb-17-17 09:07AM  Berkshires BNSF and the Latest in Local Manufacturing
Feb-16-17 01:10PM  Is CSX Corporation Stock Gearing Up for Another Huge Year After a Fantastic 2016? at Motley Fool
12:19PM  Union Pacific Tops Fortune's Most Admired in Industry PR Newswire
10:36AM  These Key Commodity Groups Drove Canadian Pacifics Carloads
Feb-15-17 01:38PM  Veteran Favored for CSX Helm Could Push Extreme Makeover
09:30AM  The Zacks Analyst Blog Highlights: ConocoPhillips, Emerson Electric, Union Pacific, Occidental Petroleum and Cardinal Health
09:07AM  Why Union Pacifics Carloads Jumped in the 5th Week of 2017
Feb-14-17 03:36PM  Behind Union Pacifics Intermodal Volumes
03:10PM  Stock Research Reports for Union Pacific, ConocoPhillips & Emerson Electric
02:06PM  Norfolk Southerns Carloads: Coal Could Be Bouncing Back
12:28PM  Let the US Freight Rail Traffic Revival Begin
09:00AM  10 Best Dividend Stocks in the Dow Averages at Kiplinger
Feb-13-17 10:36AM  Why Genesee and Wyomings European Revenue Fell in 4Q16
07:37AM  Why Genesee and Wyomings Australian Revenue Rose in 4Q16
Feb-10-17 05:09PM  Strong Volumes Drive Genesee and Wyomings North American Revenue
Feb-09-17 01:04PM  UNION PACIFIC CORP Financials
07:36AM  Boosted by Coal Volumes, Canadian Pacifics Carloads Rose
Feb-08-17 10:00AM  Union Pacific Could See a Significant Pullback in 2017
09:07AM  Why CHRWs Robinson Fresh Segmental Revenue Slumped in 4Q16
09:06AM  How Does Kansas City Southerns Intermodal Traffic Compare?
Feb-07-17 03:05PM  Why Did CHRWs North American Surface Transport Net Revenue Slide in 4Q16?
09:08AM  How Union Pacifics Intermodal Volumes Compare
08:00AM  Union Pacific Corporation CFO Rob Knight to Address the Stifel and Barclays Investor Conferences PR Newswire
07:36AM  A Look at Union Pacifics Carloads in the 4th Week of 2017
07:04AM  3 Attractive Income Stocks Whose Dividends Could Double at Motley Fool
Feb-06-17 04:29PM  US and Canada Freight Rail Weekly Traffic Up, Mexican Volume Down
Feb-03-17 04:16PM  UNION PACIFIC CORP Files SEC form 10-K, Annual Report
09:14AM  3 Dividend Stocks Trading At 10% Discount Or More at Insider Monkey
Feb-02-17 04:17PM  UNION PACIFIC CORP Files SEC form 8-K, Change in Directors or Principal Officers
01:51PM  Union Pacific Corporation Announces a $3.1 Billion Capital Plan for 2017 and Declares First Quarter 2017 Dividend PR Newswire
07:35AM  Coal Volumes Fall, Canadian Pacifics Carloads Rise
Feb-01-17 12:02PM  Industrial ETF Investors! Look at Trump, Not Soft Earnings
07:36AM  Huge Rise in Coal Boosts BNSF Railways Carloads
Jan-31-17 09:08AM  Why Did Union Pacifics Intermodal Volumes Rise?
07:39AM  What Boosted Union Pacifics Carloads?
Jan-30-17 05:06PM  Why Norfolk Southerns Carloads Increased
03:07PM  Traffic Rises 8%: Could US Freight Rail Pick up in 2017?
12:50PM  Union Pacific Is Chugging Right Along
09:30AM  Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
07:00AM  What it takes to get a Corona from Mexico to a U.S. heartland bar Reuters
Jan-27-17 03:59PM  What it takes to get a Corona from Mexico to a U.S. heartland bar Reuters
10:43AM  Union Pacific vs. CSX Earnings: How Do They Stack Up? at Motley Fool
09:07AM  Why Norfolk Southerns General Merchandise Revenue Slid in 4Q16
07:38AM  Why Norfolk Southerns Coal Revenues Slumped in 4Q16
Jan-26-17 06:00PM  Stocks Trumps 20 percent Mexico import tax, border wall could hurt and ones he might help at bizjournals.com
09:30AM  Zacks Investment Ideas feature highlights: Abb, Applied Materials, Broadcom, LyondellBassel and Union Pacific
Jan-25-17 11:27AM  Norfolk Southern (NSC) Beats on Q4 Earnings, Misses Sales
11:27AM  Union Pacific Employees Achieve Safest Year in Company History PR Newswire
08:15AM  Post Earnings Coverage as Union Pacific's Q4 Results Beat Market Estimates Accesswire
07:36AM  Why Canadian Pacifics Carloads Slumped in Second Week of 2017
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. It offers transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising industrial chemicals, plastics, fertilizers, petroleum and liquid petroleum gases, crude oil, and soda ash. The company also provides transportation services for coal, petroleum coke, and biomass; industrial products consisting of construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export container traffic. Its rail network includes 32,070 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. Union Pacific Corporation was founded in 1862 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Whited Elizabeth FEVP & CHIEF MARKETING OFFICERMar 10Option Exercise31.191,00031,19050,583Mar 13 11:36 AM
Whited Elizabeth FEVP & CHIEF MARKETING OFFICERMar 10Sale106.891,000106,89049,583Mar 13 11:36 AM
Card Andrew H JRDirectorJan 25Option Exercise24.257,400179,45022,400Jan 26 10:44 AM
Card Andrew H JRDirectorJan 25Sale109.534,000438,12918,400Jan 26 10:44 AM
MCCONNELL MICHAEL WDirectorDec 09Option Exercise24.257,400179,45026,410Dec 12 10:56 AM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Option Exercise39.1327,0681,059,287234,784Dec 12 03:30 PM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Sale104.9423,1982,434,398222,062Dec 12 03:30 PM
MCCONNELL MICHAEL WDirectorDec 09Sale105.157,400778,11919,010Dec 12 10:56 AM
ROGEL STEVEN RDirectorNov 22Option Exercise24.257,400179,45011,400Nov 23 10:51 AM
ROGEL STEVEN RDirectorNov 22Sale100.517,400743,7474,000Nov 23 10:51 AM
DUREN DIANE KEVP CHIEF ADMIN OFFICER & CORPNov 18Sale98.982,840281,103128,701Nov 21 02:14 PM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Option Exercise66.006,484427,94471,320Oct 11 08:58 AM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Sale98.446,484638,28564,836Oct 11 08:58 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 07Sale97.005,000485,00032,723Sep 09 11:09 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 01Sale95.2410,000952,41537,723Sep 02 03:51 PM
DUREN DIANE KEVP & CORPORATE SECRETARYJun 03Sale85.462,500213,650131,541Jun 06 12:25 PM
BIIB Biogen Inc. daily Stock Chart
BIIB [NASD]
Biogen Inc.
IndexS&P 500 P/E16.43 EPS (ttm)16.91 Insider Own0.10% Shs Outstand215.95M Perf Week-5.05%
Market Cap60.01B Forward P/E12.42 EPS next Y22.38 Insider Trans-16.68% Shs Float215.33M Perf Month-3.15%
Income3.70B PEG2.61 EPS next Q5.00 Inst Own89.40% Short Float1.30% Perf Quarter-0.32%
Sales11.45B P/S5.24 EPS this Y10.30% Inst Trans-0.88% Short Ratio1.68 Perf Half Y-9.50%
Book/sh56.05 P/B4.96 EPS next Y6.84% ROA17.00% Target Price317.43 Perf Year7.11%
Cash/sh22.67 P/C12.26 EPS next 5Y6.29% ROE32.20% 52W Range223.02 - 333.65 Perf YTD-2.01%
Dividend- P/FCF15.81 EPS past 5Y27.40% ROI21.00% 52W High-16.47% Beta0.78
Dividend %- Quick Ratio2.30 Sales past 5Y17.80% Gross Margin87.10% 52W Low24.96% ATR6.37
Employees7400 Current Ratio2.60 Sales Q/Q1.20% Oper. Margin45.00% RSI (14)42.23 Volatility2.56% 2.12%
OptionableYes Debt/Eq0.54 EPS Q/Q-20.60% Profit Margin32.30% Rel Volume0.58 Prev Close277.87
ShortableYes LT Debt/Eq0.54 EarningsApr 27 BMO Payout0.00% Avg Volume1.66M Price278.70
Recom2.20 SMA20-3.26% SMA50-1.50% SMA200-3.17% Volume405,965 Change0.30%
Mar-16-17Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-16-17Downgrade Leerink Partners Outperform → Mkt Perform
Mar-02-17Initiated Instinet Buy $345
Feb-07-17Upgrade Citigroup Neutral → Buy
Dec-29-16Reiterated Raymond James Strong Buy $375 → $386
Dec-09-16Reiterated Stifel Hold $291 → $298
Nov-08-16Initiated Mizuho Buy $290
Nov-07-16Upgrade Piper Jaffray Neutral → Overweight
Nov-07-16Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-16Downgrade Jefferies Buy → Hold
Jun-29-16Initiated Bernstein Outperform
Jun-07-16Downgrade Citigroup Buy → Neutral
Feb-25-16Initiated Citigroup Buy $345
Jan-20-16Initiated Credit Suisse Neutral
Jan-07-16Initiated Standpoint Research Buy $360
Dec-04-15Resumed Wells Fargo Outperform
Oct-22-15Reiterated H.C. Wainwright Buy $380 → $360
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $400
Aug-11-15Initiated H.C. Wainwright Buy $380
Mar-22-17 03:10PM  Cytokinetics SMA Drug Did Well in Early Study at Investopedia
12:53PM  Could Biogen Spinoff Bleed This Biotech In Hemophilia?
10:37AM  Recent Developments for Ionis Pharmaceuticals
08:33AM  Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
07:37AM  A Look at Ionis Pharmaceuticals Spinraza
12:07AM  [$$] Two Cheers for Biogens Court Victory at The Wall Street Journal
Mar-21-17 04:43PM  Biogen Wins Tecfidera Patent Case at Investopedia
04:04PM  Biogen Stock Pops After Judge Upholds Critical Drug Patent
02:13PM  Biogen wins patent decision
01:44PM  Biogen: Did Someone Say Biotech Stocks are Falling? at Barrons.com
12:52PM  [$$] Two Cheers for Biogen's Court Victory at The Wall Street Journal
12:26PM  Biogen wins ruling in Tecfidera IP case; shares rise
12:05PM  Understanding Ionis Pharmaceuticals 2016 Revenue Stream
11:45AM  Biogen prevails in dispute over key Tecfidera patent at bizjournals.com
09:25AM  3 Biotech Stocks That Are Broker Favorites
09:07AM  Better Buy: Ionis Pharmaceuticals, Inc. vs. Juno Therapeutics at Motley Fool
08:17AM  Biogen, Inc. breached its 50 day moving average in a Bearish Manner : BIIB-US : March 21, 2017
Mar-20-17 04:24AM  European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details
03:00AM  European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade
Mar-17-17 05:44PM  Week in Review: Stocks Post Small Gains After Fed Pulls Trigger on Third Hike Since Crisis
11:44AM  AveXis Inc Stock Is Spiking Again Today -- Here's Why at Motley Fool
10:29AM  Get Ready For A Slew of Data As Weekend Nears
10:25AM  AveXis Reports Positive Data for SMA Gene Therapy at Investopedia
07:39AM  Why Did the Healthcare Sector Fall on March 16?
Mar-16-17 04:24PM  US STOCKS-Wall St slips with healthcare stocks, Nasdaq flat
04:24PM  The Biggest Loser: Biogen Tumbles 4.7% at Barrons.com
04:05PM  Biogen Dives As Takeover Buzz Fades, Drugs Hit Snags
03:12PM  Stock market pares post-Fed bounce as health care, utilities slump at MarketWatch
02:32PM  Biogen, LendingClub, IBM, and More: Heres What Analysts Had to Say About These Five Stocks at Insider Monkey
12:58PM  US STOCKS-Wall St edges down as healthcare stocks hit by budget plan
12:13PM  Cramer: Confusion Reigns in This Market
12:08PM  Biogen stock drops 5.5% after downgrades at Morgan Stanley, Leerink at MarketWatch
11:32AM  US STOCKS-Wall St slightly lower as healthcare stocks weigh
11:25AM  Biogen: Double Trouble? at Barrons.com
10:41AM  Biogen's Catalysts May Be Waning; Leerink Downgrades To Market Perform
10:06AM  Biogen shares drop after Morgan Stanley downgrade; rest of biotech also dragged lower at CNBC
09:32AM  Morgan Stanley Takes A Breather On Biogen, Downgrades Stock
09:15AM  Analysts' Actions -- Liberty Global, RPM International, TJX, Biogen and More
07:00AM  Biogen Appoints Anirvan Ghosh Senior Vice President, Research and Early Development Business Wire
Mar-13-17 04:39PM  Biogen Spinoff Downgraded On Mounting Roche, Shire Rivalry
02:08PM  Biotech stocks are turning bullishhere's how to profit
12:51PM  Neurotrope Shares Soar as Alzheimer's Drug Trial Lottery Ticket Call Nears
09:40AM  Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise
Mar-10-17 01:12PM  AbbVie Stock Upgraded: What You Need to Know at Motley Fool
08:00AM  Biogen Spinoff Takes Flight With Focus On Hemophilia Drugs
Mar-09-17 12:38PM  3 Biotech Stocks to Buy Nowand 1 to Dump ASAP at Barrons.com
Mar-08-17 12:10PM  Biogen, Inc. :BIIB-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017
11:08AM  Pharma says high prices fund drug development. This study says otherwise at MarketWatch
09:40AM  Biogen loses another top executive as tech guru departs at bizjournals.com
Mar-07-17 04:40PM  Biogen Tech EVP Andi Karaboutis Leaves Company at The Wall Street Journal
04:22PM  5 Things Biogen's CEO Just Said That You Don't Want to Miss at Motley Fool
Mar-06-17 02:35PM  Jeff Auxier Invests in Gilead, Wells Fargo, Apple
01:18PM  Weekly CEO Buys Highlights
09:28AM  Inovio (INO): What's in the Cards this Earnings Season?
09:21AM  4 Things Alkermes Wants Investors to Know at Motley Fool
02:16AM  Israel's BrainStorm names Biogen senior executive Kern as COO Reuters
Mar-04-17 07:25PM  Icahn's (Potential) Move Into Biotech
Mar-02-17 08:42AM  Coverage initiated on Biogen by Instinet
12:37AM  Drug Companies Block Shareholder Votes on Price Transparency Proposals at The Wall Street Journal
Mar-01-17 05:07PM  [$$] Drug Companies Block Shareholders' Voting on Price Transparency at The Wall Street Journal
03:56PM  Ionis Pharmaceuticals Inc Turns a Profit With Other Drugmakers' Money at Motley Fool
01:24PM  Investors have stopped believing Trumps drug price threats at MarketWatch
10:37AM  Regeneron Could See a Modest Rise in Net Profit Margins in 2017
09:30AM  The Zacks Analyst Blog Highlights: AT&T, Visa, Biogen, Tesla and PG&E
07:30AM  [$$] Gormley's Take: With Biotech Talent In Demand, CEO Takes Helm at Two Companies at The Wall Street Journal
Feb-28-17 04:01PM  Biogen to Present at the Cowen & Company 37th Annual Health Care Conference Business Wire
02:10PM  At rare disease panel, ex-FDA new drug head preaches evidence over empathy at bizjournals.com
12:12PM  Roche Attempts New Trial for Alzheimer's at Investopedia
11:40AM  Top Research Reports for February 28, 2017
08:30AM  Accera's Alzheimer's trial fails, in yet another setback for disease Reuters
07:37AM  Understanding Alexions Profit Margin Trend in 2017
Feb-27-17 09:22PM  After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B
01:22PM  Rob Citrones Discovery Capital Management Grows Bullish on Energy, Airline and Healthcare Stocks at Insider Monkey
01:21PM  Better Buy: Biogen Inc. vs. Gilead Sciences Inc. at Motley Fool
07:15AM  Biogen alums team up to launch Waltham biotech, with backing from Henri Termeer at bizjournals.com
Feb-24-17 07:35AM  Ring the Register With These Upcoming Spinoffs
Feb-23-17 05:06PM  Teva Is Expected to See a Fall in Its Profit Margins in 2017
08:02AM  Here's Why Celgene's Latest Drug Is So Exciting at Motley Fool
Feb-22-17 09:15AM  Did Biogen Inc. Shoot Itself in the Foot? at Motley Fool
Feb-21-17 03:40PM  Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A at bizjournals.com
Feb-20-17 10:30AM  Celgene MS Drug Reports Positive Phase 3 Data at Investopedia
08:24AM  3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter at Motley Fool
07:37AM  This Keeps Driving Sanofis Growth
07:36AM  Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment
Feb-19-17 11:41AM  Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands? at Motley Fool
Feb-16-17 09:40PM  Shkreli defends drug prices, spars with protesters at heated UMass Boston event at bizjournals.com
09:37PM  Tesaro sees a $5B market opportunity for its cancer drug at bizjournals.com
09:27AM  Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb-15-17 07:34PM  Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next? at Motley Fool
05:29PM  Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference Business Wire
04:18PM  Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next?
10:46AM  Merck Halts Late-Stage Alzheimers Drug Trial at Investopedia
07:18AM  Bioverativ's hemophilia hopes
07:00AM  Another Alzheimer's Drug Study Fails. This Time It's Merck's. at Forbes
Feb-13-17 03:52PM  Key Presenters At Leerink's Healthcare Conference
02:25PM  Regeneron: It's All Riding On Dupixent at Barrons.com
09:00AM  Biogens Spinraza Faces Insurance Coverage Hurdles at Investopedia
Feb-12-17 07:43AM  A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease at Motley Fool
Feb-10-17 04:14PM  Is Biogen a Risky Stock? at Motley Fool
09:55AM  Major Biotechs Scare Off Loads of Short Sellers
Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company's Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin's lymphoma; and Aducanumab and E2609 for Alzheimer's disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer's disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company's Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson's disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Clancy Paul JExecutive VP and CFOMar 13Sale291.559,8912,883,72120,705Mar 14 07:32 PM
McKenzie PaulEVP Pharmaceutical Oper & TechMar 01Option Exercise0.004810718Mar 03 06:07 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratMar 01Sale290.07973282,2389,041Mar 03 06:02 PM
Clancy Paul JExecutive VP and CFOFeb 28Option Exercise0.006,780031,948Mar 02 05:24 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 28Option Exercise0.004,785010,398Mar 02 05:22 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 28Option Exercise0.005,559036,024Mar 02 05:20 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 28Option Exercise0.0068104,508Mar 02 05:18 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffFeb 28Option Exercise0.002,06409,237Mar 02 05:16 PM
DiPietro KennethEVP Human ResourcesFeb 28Option Exercise0.005,69608,260Mar 02 05:12 PM
Vounatsos MichelChief Executive OfficerFeb 27Buy285.391,333380,4251,434Mar 01 04:18 PM
PANGIA ROBERT WDirectorJan 09Option Exercise52.225,450284,59922,078Jan 10 04:15 PM
PANGIA ROBERT WDirectorJan 09Sale295.395,4501,609,87616,628Jan 10 04:15 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffDec 01Sale296.534814,2337,360Dec 05 04:34 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 04Sale311.9426281,7287,579Oct 05 04:24 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 03Sale313.00380118,9407,841Oct 04 05:02 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 01Option Exercise0.001,98209,154Oct 04 05:02 PM
DORSA CAROLINEDirectorSep 22Option Exercise53.6427,5701,478,85544,663Sep 26 04:24 PM
DORSA CAROLINEDirectorSep 22Sale314.0027,5708,656,98017,093Sep 26 04:24 PM
SCANGOS GEORGE AChief Executive OfficerJul 21Sale280.0015743,96054,779Jul 22 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 06Sale290.00555160,9502,402Jun 07 04:09 PM
SCANGOS GEORGE AChief Executive OfficerJun 03Sale290.00842244,18054,936Jun 06 08:14 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 02Option Exercise0.001,64303,491Jun 06 08:48 PM
SCANGOS GEORGE AChief Executive OfficerJun 01Sale287.97487140,24155,778Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 31Sale290.003,368976,72056,265Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 25Sale280.0015743,96059,633May 27 08:59 AM
SCANGOS GEORGE AChief Executive OfficerMay 02Sale274.74487133,79859,790May 04 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Apr 06Sale275.0010228,0501,848Apr 07 05:03 PM
SCANGOS GEORGE AChief Executive OfficerApr 06Sale280.0015743,96060,277Apr 07 05:01 PM
Artavanis-Tsakonas SpyridonEVP, Chief Scientific OfficerApr 02Option Exercise0.0097503,609Apr 05 05:06 PM
SCANGOS GEORGE AChief Executive OfficerApr 01Sale258.83487126,05060,434Apr 05 05:02 PM
UNH UnitedHealth Group Incorporated daily Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E23.04 EPS (ttm)7.25 Insider Own0.50% Shs Outstand951.17M Perf Week-2.77%
Market Cap158.87B Forward P/E15.70 EPS next Y10.64 Insider Trans-3.46% Shs Float935.16M Perf Month4.41%
Income7.02B PEG1.48 EPS next Q2.17 Inst Own89.00% Short Float0.79% Perf Quarter3.78%
Sales184.84B P/S0.86 EPS this Y20.60% Inst Trans-0.08% Short Ratio2.15 Perf Half Y22.44%
Book/sh40.20 P/B4.15 EPS next Y11.94% ROA5.80% Target Price184.55 Perf Year32.69%
Cash/sh10.97 P/C15.23 EPS next 5Y15.56% ROE19.00% 52W Range123.17 - 172.14 Perf YTD4.76%
Dividend2.50 P/FCF27.26 EPS past 5Y8.90% ROI11.40% 52W High-3.31% Beta0.64
Dividend %1.50% Quick Ratio- Sales past 5Y12.70% Gross Margin- 52W Low35.13% ATR2.18
Employees230000 Current Ratio- Sales Q/Q9.00% Oper. Margin7.00% RSI (14)50.08 Volatility1.27% 1.16%
OptionableYes Debt/Eq0.86 EPS Q/Q38.10% Profit Margin3.80% Rel Volume0.70 Prev Close167.03
ShortableYes LT Debt/Eq0.67 EarningsApr 18 BMO Payout32.20% Avg Volume3.45M Price166.44
Recom1.60 SMA20-0.69% SMA501.89% SMA20012.25% Volume1,015,185 Change-0.35%
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Upgrade Cantor Fitzgerald Hold → Buy
Nov-30-16Upgrade Mizuho Neutral → Buy $178
Nov-30-16Reiterated RBC Capital Mkts Outperform $168 → $175
Nov-09-16Downgrade Mizuho Buy → Neutral
Oct-19-16Reiterated Mizuho Buy $160 → $169
Jul-22-16Upgrade Argus Hold → Buy
Jul-20-16Reiterated RBC Capital Mkts Outperform $157 → $165
Jul-19-16Reiterated Mizuho Buy $156 → $160
Jun-16-16Initiated Bernstein Outperform
Jun-13-16Reiterated Mizuho Buy $156 → $156
Apr-20-16Reiterated Mizuho Buy $150 → $156
Apr-19-16Reiterated FBR Capital Outperform $130 → $145
Mar-15-16Reiterated Mizuho Buy $131 → $150
Dec-16-15Initiated Credit Suisse Outperform
Nov-20-15Reiterated Mizuho Buy $155 → $131
Nov-19-15Reiterated FBR Capital Outperform $135 → $130
Oct-02-15Initiated Citigroup Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-09-15Resumed Morgan Stanley Overweight $140
Mar-23-17 09:32AM  Should HCA Holdings (HCA) Stock Be in Your Portfolio Now?
08:41AM  The biggest institutional investors are gobbling up this stock at CNBC
Mar-22-17 06:14PM  4 Reasons Why UnitedHealth (UNH) Stock Looks Attractive Now
11:40AM  Feds probe Humana on false claims to Medicare at bizjournals.com
11:00AM  How Mobile Apps Reduce Follow-Up Visits After Surgery at Forbes
09:40AM  Hedge Funds Love These 4 Stocks -- Should You?
09:30AM  The Zacks Analyst Blog Highlights: Wal-Mart, UnitedHealth, Charter Communications, ExxonMobil and Caterpillar
07:15AM  Health care stocks under GOP plan
06:50AM  UnitedHealth Group Schedules First Quarter Earnings Release and Conference Call for April 18, 2017 Business Wire
Mar-21-17 03:53PM  Health Insurance Lobby Backs Key Trumpcare Revisions at Forbes
03:30PM  ACA Repeal Faces Dire Prognosis
01:35PM  Top Research Reports for Wal-Mart, Charter & UnitedHealth
Mar-20-17 10:15AM  UnitedHealth Extends Expiration Date of SCA Share Exchange
08:30AM  Best HSAs Offer Low Fees, Many Investment Options And Flexible Management
Mar-19-17 09:31AM  U.S. Republicans working on Medicaid, tax credit changes-Ryan Reuters
Mar-18-17 01:00PM  Obamacare Repeal to Cut Deficit, but Greatly Expand Ranks of Uninsured
Mar-17-17 05:22PM  UnitedHealth Group Announces Extension of Exchange Offer to Acquire Surgical Care Affiliates, Inc. Business Wire
02:35PM  U.S. investigates four insurers over Medicare payments Reuters
01:06PM  U.S. probing insurers beyond UnitedHealth over Medicare charges Reuters
Mar-16-17 02:10PM  Metalmark-owned Bostwick Labs files bankruptcy at bizjournals.com
12:13PM  GOP Opponents Silent as Budget Panel Takes Up ACA Repeal
Mar-15-17 07:14PM  6 trades to make at all-time highs at CNBC
07:01PM  Cramer: The Airlines and Health-Care Names Are Really Soaring
06:29PM  US Market Indexes Gain and Fed Raises Rate
05:52PM  Fast Money Madness goes head-to-head on health care
05:00PM  6 trades to make at all-time highs
04:35PM  Express Scripts Downgraded On Fear It Could Lose Anthem Contract
04:01PM  Caterpillar, Verizon Push DJIA Higher Wednesday
10:41AM  Stocks Up Ahead Of Fed As Apple, Nike Lift Dow; Will Apple Form New Base?
Mar-14-17 05:44PM  US Market Indexes Lower With Losses Led by Chevron
04:17PM  Health Care Stocks Socked Again After CBO RyanCare Score
12:12PM  Health Insurers in Bull Market Territory Despite Iffy American Health Care Act
Mar-13-17 04:29PM  UNITEDHEALTH GROUP INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:11PM  UnitedHealth's Rally Is Far From Over
11:48AM  New highs for the CNBC IQ 100
06:51AM  Street eyes battle for health care control
Mar-11-17 09:55AM  Huge Real Estate and Health Care Trades Highlight Insider Selling: Regency Centers, Allegan, UnitedHealthcare, Wyndham and More
Mar-10-17 05:56PM  US Market Indexes Higher Friday With Losses for the Week
04:27PM  Stock market ends higher after solid jobs report but snaps weekly win streak at MarketWatch
04:04PM  UNITEDHEALTH GROUP INC Files SEC form 8-K, Regulation FD Disclosure
04:01PM  General Electric, Caterpillar Push DJIA Higher Friday
10:18AM  House leader: 'very difficult' to speed up end to Medicaid expansion Reuters
09:23AM  UnitedHealth's Senior Unsecured Notes Rated by A.M Best
Mar-09-17 01:55PM  A.M. Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporateds New Senior Unsecured Notes Business Wire
01:14PM  Big winners & losers since Haines Bottom
12:15PM  Norwood Elementary in West Jefferson Awarded $20,000 PLAYMAKERS Grant from UnitedHealthcare Business Wire
11:09AM  Obamacare Repeal Heads to House Floor After 18 Hours of Debate
10:45AM  The Bull Market Turns 8: These Dow Stocks Led the Way Higher at Motley Fool
10:40AM  Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
09:38AM  UnitedHealth's (UNH) Senior Unsecured Debt Rated by Moody's
Mar-08-17 03:05PM  UnitedHealth Group Incorporated -- Moody's rates UnitedHealth Group's senior notes A3; outlook negative at Moody's
03:00PM  What Happens at UnitedHealth Group If Obamacare Is Replaced at Motley Fool
01:48PM  UnitedHealth Group, Inc. :UNH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017
01:46PM  Why UnitedHealth Would Not Be Affected By Obamacare Repeal at Forbes
01:07PM  The Biggest Puzzle About Paul Ryan's ObamaCare Repeal
10:49AM  Health Insurers Hit 52-Week Highs: What's Behind the Rise?
10:23AM  Obamacare vs. the Republican plan for those thinking of skipping health insurance at MarketWatch
09:25AM  AMA Says Trumpcare Is 'Critically Flawed' at Forbes
09:00AM  AARP Services, UnitedHealthcare Announce Fall Prevention Challenge, Issue Call To Innovators PR Newswire
12:33AM  [$$] Health-Care Overhaul Gets a Shrug From Wall Street at The Wall Street Journal
Mar-07-17 05:00PM  Winners and losers of new GOP health care plan
05:00PM  5 ways to trade health care after AHC unveil
04:55PM  Stocks today: Dow, S&P 500 slip as rally pauses on Obamacare repeal; Trump talks tax cuts right before closing bell at bizjournals.com
04:13PM  Three Reasons TrumpCare Isn't Killing Hospital, Insurer Stocks
03:09PM  Trump endorses House Republican healthcare plan, opposition grows Reuters
12:53PM  [$$] Health-Care Overhaul Gets a Shrug From Wall Street at The Wall Street Journal
12:43PM  Are There Any Winners From The GOP Health Care Plan? at Barrons.com
10:37AM  Will Obamacare Repeal Make Healthcare Stocks Sick? at Barrons.com
10:36AM  Ten stocks to watch with focus on Obamacare, drug prices; Dow Jones dips; Snap slides 10 percent early at bizjournals.com
09:50AM  Stocks Open Lower; Dish Network Jumps On Move To S&P 500
09:01AM  Cramer: Getting rid of state lines would promote competit...
07:54AM  Early movers: DKS, MIK, NAV, PFE, AET, CSX, & more at CNBC
06:31AM  What's working: Health care stocks after Obamacare
Mar-06-17 04:21PM  [$$] Alliance of Companies Unveil First Steps to Cutting Health-Care Costs at The Wall Street Journal
Mar-05-17 02:03PM  3 Stocks to Buy As Obamacare Collapses at Motley Fool
09:02AM  Rift Widens, Fractures Grow Among Republicans On Obamacare at Forbes
07:43AM  Everything You Need to Know About the Republican Bill to Replace Obamacare at Motley Fool
Mar-02-17 03:25PM  J. Watson Bailey Takes Home Top Prize in 2017 UnitedHealthcare Health Bee in Kingston Business Wire
09:03AM  78% of Americans Support This Revolutionary Healthcare Technology, but Only 21% Have Tried It at Motley Fool
Mar-01-17 05:55PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Surgical Care Affiliates, Inc. - SCAI PR Newswire
04:13PM  Sarepta Stock Seesaws On 2017 Duchenne Muscular Dystrophy Guide
10:04AM  Trump's Big Speech Leaves Investors With Hope, Not Much Else
Feb-28-17 05:40PM  3 Top Dividend Stocks to Buy Now at Motley Fool
03:58PM  Does Trump really know how to fix Americans health care? at MarketWatch
Feb-27-17 06:54PM  Trading health care as industry CEOs meet with Trump at CNBC
05:10PM  Stocks move higher, Dow and S&P 500 edge to records after Trump talk at bizjournals.com
05:08PM  Health care best Trump trade?
04:01PM  Caterpillar, Chevron Lead DJIA Higher Monday
03:47PM  United Health Foundation and Medical College of Wisconsin to Launch Coordinated Care Program for New and Expectant Mothers Business Wire
11:32AM  Trump meets insurers, promises catastrophic year for Obamacare Reuters
01:48AM  [$$] Health Insurers Hope for Nothing at The Wall Street Journal
Feb-26-17 07:36PM  Dow, S&P 500 Set To Open At Highs: Workday, Priceline Earnings Due; Trump Looms
01:14PM  [$$] Health Insurers Hope for Nothing at The Wall Street Journal
Feb-24-17 04:33PM  [$$] Trump to Meet With Insurance Executives on Repeal of Affordable Care Act at The Wall Street Journal
12:12PM  JPMorgan Fund Boosts Retirement Accounts With Hot Stocks
Feb-23-17 06:29PM  Dow Jones Leads Market Gains on Thursday
04:01PM  Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday
12:39PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of UnitedHealth Group Inc. and Advises Investors with Losses to Contact the Firm Business Wire
Feb-22-17 05:02PM  Health giant to lay off 119 in Denver area at bizjournals.com
10:36AM  Top Research Reports for February 22, 2017
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company's UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 1 million physicians and other health care professionals, as well as approximately 6,000 hospitals and other facilities. Its OptumHealth segment offers health management services, including care delivery and management, wellness and consumer engagement, distribution, and health financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company's OptumInsight segment provides software and information products, and business process outsourcing and support services to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. Its OptumRx segment offers pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOOPER MICHELE JDirectorMar 16Option Exercise39.5215,000592,75035,941Mar 20 04:50 PM
HOOPER MICHELE JDirectorMar 16Sale170.8915,0002,563,34530,941Mar 20 04:50 PM
DARRETTA ROBERT JDirectorMar 15Option Exercise54.0216,621897,94955,134Mar 16 05:02 PM
BURKE RICHARD TDirectorMar 02Sale167.4850,0008,373,9251,871,191Mar 06 04:52 PM
WILENSKY GAIL RDirectorFeb 23Option Exercise53.785,310285,56760,175Feb 24 04:42 PM
WILENSKY GAIL RDirectorFeb 23Sale162.315,310861,88555,175Feb 24 04:42 PM
BALLARD WILLIAM C JRDirectorFeb 14Option Exercise53.735,000268,65075,391Feb 15 04:50 PM
BALLARD WILLIAM C JRDirectorFeb 14Sale162.685,000813,40070,391Feb 15 04:50 PM
BURKE RICHARD TDirectorJan 31Sale161.6810,0001,616,7501,921,191Feb 02 05:28 PM
BURKE RICHARD TDirectorJan 23Option Exercise52.2189046,4671,931,191Jan 25 04:17 PM
BURKE RICHARD TDirectorDec 29Option Exercise52.575,000262,8501,930,030Jan 03 04:34 PM
Bueno Edson de GodoyDirectorDec 21Option Exercise55.0357,2003,147,716207,817Dec 22 08:55 PM
BURKE RICHARD TDirectorDec 15Sale159.8015,0002,397,0001,925,030Dec 15 04:36 PM
BURKE RICHARD TDirectorDec 08Sale158.6645,0007,139,4891,944,949Dec 09 04:09 PM
ROOS THOMAS EChief Accounting OfficerDec 06Sale157.602,000315,20321,083Dec 08 04:24 PM
WILENSKY GAIL RDirectorNov 17Option Exercise52.545,460286,86760,512Nov 21 04:10 PM
WILENSKY GAIL RDirectorNov 17Sale150.555,460822,00055,052Nov 21 04:10 PM
BALLARD WILLIAM C JRDirectorNov 14Sale151.213,000453,61570,039Nov 16 04:22 PM
WILSON D ELLENEVP Human CapitalOct 21Option Exercise46.1816,275751,58066,635Oct 25 05:07 PM
Shine Kenneth IrwinDirectorOct 21Sale144.9932547,12128,613Oct 25 05:08 PM
WILSON D ELLENEVP Human CapitalOct 21Sale144.1814,3652,071,10552,270Oct 25 05:07 PM
BURKE RICHARD TDirectorSep 14Option Exercise49.325,990295,4421,989,540Sep 15 05:13 PM
BURKE RICHARD TDirectorSep 07Sale135.3140,0005,412,2161,983,550Sep 09 04:52 PM
BALLARD WILLIAM C JRDirectorAug 25Option Exercise52.575,000262,85072,630Aug 29 04:32 PM
BALLARD WILLIAM C JRDirectorJun 16Option Exercise49.435,000247,15072,229Jun 20 04:27 PM
BURKE RICHARD TDirectorJun 16Option Exercise45.415,840265,2192,023,149Jun 20 04:28 PM
BALLARD WILLIAM C JRDirectorJun 16Sale138.585,000692,89567,229Jun 20 04:27 PM
BURKE RICHARD TDirectorMay 13Sale129.3025,0003,232,5332,017,309May 17 04:34 PM
Shine Kenneth IrwinDirectorApr 20Option Exercise25.1662515,72528,680Apr 22 04:18 PM
BALLARD WILLIAM C JRDirectorApr 20Option Exercise45.015,000225,05073,229Apr 22 04:18 PM
BALLARD WILLIAM C JRDirectorApr 20Sale134.875,000674,35568,229Apr 22 04:18 PM
Shine Kenneth IrwinDirectorApr 20Sale132.29962127,26628,055Apr 22 04:18 PM
BURKE RICHARD TDirectorMar 29Option Exercise54.689,290508,0022,041,972Mar 30 04:49 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E25.60 EPS (ttm)1.06 Insider Own0.30% Shs Outstand2.12B Perf Week-0.99%
Market Cap57.53B Forward P/E17.42 EPS next Y1.56 Insider Trans0.35% Shs Float1.43B Perf Month-5.67%
Income2.50B PEG3.54 EPS next Q0.32 Inst Own37.00% Short Float1.52% Perf Quarter3.98%
Sales23.02B P/S2.50 EPS this Y-20.90% Inst Trans2.84% Short Ratio5.02 Perf Half Y1.84%
Book/sh10.45 P/B2.60 EPS next Y11.93% ROA4.90% Target Price32.96 Perf Year8.00%
Cash/sh0.03 P/C907.35 EPS next 5Y7.23% ROE11.50% 52W Range23.56 - 30.25 Perf YTD0.37%
Dividend1.64 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-9.72% Beta0.90
Dividend %6.04% Quick Ratio0.60 Sales past 5Y-12.30% Gross Margin14.70% 52W Low15.92% ATR0.41
Employees6800 Current Ratio0.80 Sales Q/Q5.30% Oper. Margin15.60% RSI (14)39.45 Volatility1.40% 1.47%
OptionableYes Debt/Eq1.07 EPS Q/Q-49.30% Profit Margin10.90% Rel Volume1.68 Prev Close27.14
ShortableYes LT Debt/Eq0.96 EarningsMay 01 BMO Payout132.30% Avg Volume4.31M Price27.31
Recom1.60 SMA20-1.50% SMA50-2.82% SMA2000.00% Volume3,038,890 Change0.63%
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
Mar-22-17 07:37AM  What Does ONEOKs Current Valuation Indicate?
07:36AM  Is Kinder Morgan Attractively Valued?
Mar-21-17 10:41AM  Better Buy: Kinder Morgan, Inc. vs. Enterprise Products Partners L.P. at Motley Fool
10:24AM  Weakness in ONEOK Continues, Stock Fell 2.8% Last Week
08:36AM  The 3 Best Stocks to Profit From Low Interest Rates While They Last at Motley Fool
Mar-20-17 02:05PM  Why MLPs Continue to Be Attractive
Mar-18-17 10:32AM  Hate Risk? You'll Love These 2 Dividend Stocks at Motley Fool
08:10AM  Like Big Dividends? The I Bet You'll Love These 3 Stocks at Motley Fool
Mar-17-17 10:54AM  Enterprise Products Partners LP : EPD-US: Dividend Analysis : January 31st, 2017 (record date) : By the numbers : March 17, 2017
07:35AM  Is Enbridge Energy Partners Attractively Valued?
Mar-16-17 10:00AM  Can This 10% Dividend Even Survive? at Motley Fool
09:35AM  Houston energy co. wins midstream assets in bankruptcy auction at bizjournals.com
Mar-15-17 03:43PM  [$$] Enterprise Products Partners Buying Assets of Azure Midstream at The Wall Street Journal
01:36PM  Enterprise Acquires Azure Natural Gas Gathering System Business Wire
08:31AM  The 5 Best Dividend Stocks of 2027 at Motley Fool
Mar-14-17 03:32PM  Top Natural Gas Stocks to Buy in 2017 at Motley Fool
09:07AM  Is Williams Companies Currently Undervalued?
Mar-13-17 04:22PM  [$$] Azure Midstream's Assets Fetch $189 Million at Auction at The Wall Street Journal
11:25AM  Enterprise Products Partners Favored by Analysts at Investopedia
10:37AM  A Look at MLPs with an Attractive Potential Upside
Mar-10-17 05:07PM  Are MLPs Still Undervalued?
04:23PM  Better Pipeline Dividend Stock Buy: Kinder Morgan or Enterprise Products?
Mar-09-17 09:44AM  4 High-Yield Dividend Stocks You Don't Have to Babysit at Motley Fool
07:24AM  Enterprise (EPD) Closes Seaway Pipeline After Potential Leak
Mar-07-17 04:35PM  What Williams Companies Current Valuation Indicates
10:42AM  Which Midstream Stocks Have the Highest Implied Volatility?
09:20AM  3 Energy Stocks We Can't Help but Love at Motley Fool
08:00AM  Enterprise Products Partners to Host Analyst Day Business Wire
Mar-06-17 03:41PM  Enterprise Products Partners' Seaway pipeline shut after leak -traders
11:23AM  Enterprise Products Partners' Seaway pipeline shut after leak: traders
Mar-02-17 01:04PM  ENTERPRISE PRODUCTS PARTNERS L P Financials
07:38AM  What Analysts Recommend for ONEOK after 4Q16 Results
Mar-01-17 12:39PM  ONEOKs 4Q16 Earnings: Effect of Natural Gas, NGL Volumes
Feb-27-17 08:00AM  Enterprise Products Partners to Participate in Investor Conferences Business Wire
Feb-24-17 01:10PM  2016 K-1 Tax Packages for Enterprise Products Partners L.P. Business Wire
11:05AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-K, Annual Report
10:09AM  Enterprise Products Partners L.P. 2016 Form 10-K Now Available Business Wire
Feb-23-17 04:15PM  Enterprise Signs Natural Gas Processing Agreements with Producers from Wyomings Green River Basin Business Wire
10:41AM  Energy Transfer says Dakota Access pipeline 99 pct complete Reuters
Feb-22-17 10:06AM  3 Value Stocks Senior Citizens Could Buy Right Now at Motley Fool
09:06AM  79% of Analysts Recommend a Hold for ONEOK
08:24AM  Analyzing US Crude Oil Movement by Rail in November 2016
Feb-21-17 05:23PM  ETEs Implied Volatility Rises ahead of Its Earnings
01:50PM  Houston co. calls for commitments on new pipeline project at bizjournals.com
10:35AM  Is Kinder Morgan Attractively Valued?
Feb-17-17 03:00AM  Houston midstream companies poised for growth on industry optimism at bizjournals.com
Feb-16-17 12:35PM  Will Targa Resources Increase Its Dividend in 2017?
Feb-12-17 10:20AM  Despite Record Market Highs, Insider Buying Jumps: Walgreens, Arconic, Qualcomm, Enterprise Products Partners and More
03:02AM  Insider Buys Highlight for Week of Feb. 6
Feb-10-17 09:07AM  Will Targa Resources Stock Generate High Returns in 2017?
Feb-08-17 10:38AM  How Have Enbridge Energy Partners Price Targets Changed?
Feb-07-17 06:37PM  Enterprise Products Maintains Upward Momentum at Investopedia
10:28AM  NGL Energys Implied Volatility Rose before Its Earnings Results
08:15AM  Post Earnings Coverage as Hess Reported Better Than Expected Results Accesswire
Feb-04-17 11:46AM  1 Energy Stock With a Better Dividend Than Helmerich & Payne, Inc. at Motley Fool
Feb-03-17 10:45AM  Magellan Midstreams Distributable Cash Flow Rose 8% in 4Q16
Feb-02-17 02:35PM  Plains All Americans Segments: Gauging 4Q16 Performance
01:07PM  ETFs with exposure to Enterprise Products Partners LP : February 2, 2017
12:55PM  Plains All Americans 4Q16 Earnings: Behind the Expectations
12:46PM  Enterprise says Seaway pipeline to resume service by Feb. 7
10:53AM  2 Stocks With Better Dividends Than Kinder Morgan, Inc. at Motley Fool
10:15AM  Enterprise Products Partners Management Sees Some Bright Times Ahead in 2017 at Motley Fool
Feb-01-17 04:43PM  Enterprise Products Partners Is Steady as She Goes
01:39PM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 1, 2017
12:15PM  [$$] Ruptured U.S. Oil Pipeline May Restart In 'A Few' Days at The Wall Street Journal
11:00AM  Enterprise Products Partners Has a Solid Business
08:20AM  Enterprise Products Partners (EPD) Misses on Q4 Earnings
Jan-31-17 03:35PM  Analysts Are Still Bullish on Enterprise Products Partners
02:05PM  What Drove Enterprise Products Partners 4Q16 Earnings Growth?
12:32PM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: 2016 By the Numbers : January 31, 2017
12:25PM  Enterprise Products Reports 1.5% Rise in Its 4Q16 EBITDA
11:46AM  Whats behind EnLink Midstreams High Implied Volatility?
11:43AM  [$$] Shutdown of Texas Pipeline Boosting Oil Prices at The Wall Street Journal
09:17AM  Decoding US Crude Oil Movement by Rail in October 2016
08:43AM  [$$] Texas Pipeline, Highway Remain Shut After Rupture at The Wall Street Journal
08:28AM  Enterprise Products Partners' Earnings Showed It Kept the Ship Steady Throughout 2016 at Motley Fool
Jan-30-17 09:35PM  Enterprise Products Partners to expand Permian pipeline by 50 percent at bizjournals.com
03:44PM  Edited Transcript of EPD earnings conference call or presentation 30-Jan-17 3:00pm GMT
12:37PM  Top 5 Oil Stocks for 2017 at Investopedia
10:00AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today
07:07AM  Q4 2016 Enterprise Products Partners LP Earnings Release - Before Market Open
06:12AM  Enterprise Products misses 4Q profit forecasts
06:05AM  Enterprise to Build Isobutane Dehydrogenation Unit Business Wire
06:00AM  Enterprise Reports 2016 Results Business Wire
Jan-28-17 01:26PM  3 High-Yield Dividend Stocks to Buy in February at Motley Fool
06:23AM  Earnings, Not Politics, Are Still Driving This Market: Cramer's 'Mad Money' Recap (Friday 1/27/17)
Jan-27-17 08:32AM  Should You Buy Enterprise Products Partners (EPD) Ahead of Earnings?
08:05AM  What's in Store for Exxon Mobil (XOM) this Earnings Season?
Jan-26-17 03:45PM  Enterprise Products Breaks Out Before Ex-Dividend Day at Investopedia
07:38AM  63% of Analysts Call Magellan a Buy ahead of Its 4Q16 Results
07:36AM  How Analysts Rate Enterprise Products ahead of Its 4Q16 Earnings
Jan-25-17 10:36AM  What Does Enterprise Products Partnerss Leverage Indicate?
10:19AM  Enterprise Products (EPD) Q4 Earnings: Is a Beat in Store?
09:07AM  What Could Drive Enterprise Products Partnerss Growth?
07:37AM  Could 4Q16 Results Impact Enterprise Products Partners Stock?
Jan-24-17 10:38AM  Falling Contribution of Gas Gathering, Processing to EPDs Income
09:07AM  How Are EPDs Segments Expected to Perform in 4Q16?
07:39AM  Enterprise Products Is Expected to Report Higher 4Q16 Earnings
Jan-20-17 09:30AM  The Zacks Analyst Blog Highlights: Hess, RPC, Chevron, Anadarko Petroleum and Enterprise Products Partners
Jan-19-17 09:45AM  Plains All American to boost capacity on Permian Basin to Corpus Christi pipeline at bizjournals.com
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,670 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas and ethane export terminals, and related operations. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 440 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,120 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 686 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates approximately 4,250 miles of refined products pipelines; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Edwin EAdvisory DirectorMar 06Sale28.0215,000420,300420,654Mar 06 05:18 PM
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-3.12 Insider Own0.10% Shs Outstand335.22M Perf Week-2.78%
Market Cap78.44B Forward P/E13.12 EPS next Y17.84 Insider Trans-16.00% Shs Float334.72M Perf Month-5.06%
Income-1219.50M PEG- EPS next Q3.37 Inst Own93.10% Short Float4.20% Perf Quarter21.87%
Sales14.57B P/S5.38 EPS this Y63.30% Inst Trans-7.23% Short Ratio3.86 Perf Half Y-1.68%
Book/sh199.95 P/B1.17 EPS next Y11.20% ROA10.90% Target Price268.50 Perf Year-15.35%
Cash/sh39.45 P/C5.93 EPS next 5Y13.81% ROE19.60% 52W Range183.98 - 281.79 Perf YTD11.74%
Dividend2.80 P/FCF96.42 EPS past 5Y-28.70% ROI0.10% 52W High-15.92% Beta1.11
Dividend %1.20% Quick Ratio2.20 Sales past 5Y26.00% Gross Margin87.20% 52W Low28.79% ATR3.36
Employees16700 Current Ratio2.30 Sales Q/Q7.10% Oper. Margin-12.50% RSI (14)50.52 Volatility1.24% 1.36%
OptionableYes Debt/Eq0.47 EPS Q/Q85.60% Profit Margin- Rel Volume0.59 Prev Close233.99
ShortableYes LT Debt/Eq0.42 EarningsFeb 08 BMO Payout0.00% Avg Volume3.64M Price236.94
Recom2.00 SMA20-1.78% SMA501.66% SMA2003.95% Volume909,378 Change1.26%
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Mar-23-17 11:24AM  Insys Therapeutics' Syndros Gets Final DEA Rule at Investopedia
10:19AM  Allergan's Restasis Now Available in Multidose Bottle in U.S.
09:06AM  Teva Denies Reports About 11% Global Workforce Reduction (TEVA) at Investopedia
08:59AM  The Supreme Court could fundamentally change America's broken patent system
Mar-22-17 06:45PM  Companies Spend Less on Share Buybacks for Second Year in 2016
04:35PM  Allergan, Dow's Apple Lead Q4 Buybacks; Health Care Atop S&P 500
02:52PM  Allergan Stock Reacts Well In Downtrodden Sector at Investopedia
10:30AM  Latest Editas research pact could be worth up to $1 billion at bizjournals.com
07:31AM  Allergan Announces Availability of RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle PR Newswire
Mar-21-17 05:35PM  David Tepper Takes Big Risks for Big Rewards
05:26PM  FDA Links Breast Implants To A Rare Form Of Cancer
02:58PM  Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar-20-17 04:51PM  Editas Get A Vetr Upgrade To Strong Buy
01:53PM  Allergan Is Setting Up Nicely for a Possible Move at Investopedia
07:31AM  JUVÉDERM VOLLURE XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21 PR Newswire
Mar-17-17 09:27AM  Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded
Mar-16-17 03:36PM  Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make? at Barrons.com
12:35PM  Court allows Allergan shareholders to go after Ackman, Valeant as a class at bizjournals.com
06:11AM  When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)
Mar-15-17 07:15PM  How to maneuver CEO buybacks
06:53PM  Cramer on how investors should maneuver CEO buybacks
06:35PM  Cramer on how investors should maneuver amid CEO buybacks at CNBC
05:46PM  Allergan (AGN) and Editas Tie Up to Treat Eye Diseases
10:37AM  David Tepper on Allergan: Does It Look Cheap?
Mar-14-17 05:24PM  Here's Why Editas Medicine Gained as Much as 17.2% Today at Motley Fool
04:30PM  Allergan plc and Editas Medicine Inc Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases Call scheduled for 4:30 pm ET today
04:19PM  Common explains why he's fighting against a blindness epidemic most people don't know about
03:05PM  Pfizer Unveils Zavicefta Antibiotic in Germany, UK at Investopedia
02:03PM  Ackman's winners & losers
01:48PM  Bill Ackman Is Done Losing Money on Valeant
01:12PM  Ackman's minus touch
11:25AM  CRISPR Could Change The World, But Right Now $90 Million Is Enough at Forbes
11:15AM  Allergan, Editas In Gene-Editing Eye Disease Pact at Investopedia
09:59AM  Allergan, Editas Sign Gene-Editing Pact for Rare Eye Diseases
09:26AM  Biotech Premarket Movers: Editas, Amphastar, Aratana, Pacira
09:17AM  New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior PR Newswire
09:10AM  Award Winning Actor And Hip-Hop Artist Common Joins Allergan's See America(SM) Initiative To Further The Fight Against Preventable Blindness PR Newswire
09:00AM  Editas bags $90M in gene editing R&D pact with Allergan at bizjournals.com
08:35AM  Editas Medicine surges 8% on $90 million Allergan research and development deal at MarketWatch
08:22AM  Allergan signs deal with Editas for gene-editing-based eye treatments
08:00AM  Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases PR Newswire
08:00AM  Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases GlobeNewswire
12:02AM  [$$] William Ackmans Pershing Square Sold Stake in Valeant at The Wall Street Journal
Mar-13-17 09:59PM  [$$] Pershing Square Sold Stake in Valeant at The Wall Street Journal
06:25PM  Food And Drug Administration Accepts Allergan PLC (AGN) Vraylar For Review As A Supplemental Drug at Insider Monkey
04:25PM  Lilly, Merck, Allergan Top Analyst's View For 2017 Pharma
11:18AM  Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks at Insider Monkey
09:40AM  Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise
01:00AM  Google, Apple, Starbucks: Doug Kass' Views
01:00AM  Allergan, Schlumberger, Caterpillar: Doug Kass' Views
Mar-10-17 05:57PM  Trump nominates FDA head with deep ties to drug companies Reuters
01:20PM  And the winner is? Who took home life sciences industry awards last night at bizjournals.com
10:28AM  Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?
Mar-09-17 02:00PM  Allergan plc Question if a Feminist Can Love Fillers? PR Newswire
10:55AM  Allergan's (AGN) Vraylar sNDA Accepted for Review by FDA
Mar-08-17 04:13PM  Battered Biotech Teva Is a Smart Contrarian Buy Now
04:08PM  David Tepper Discusses Allergan Investment, Market Valuation
01:52PM  The Tepper blitz on The Halftime Report
09:27AM  Hedge Fund Guru Tepper Bullish on Allergan at Investopedia
08:00AM  FDA Accepts Supplemental New Drug Application (sNDA) For VRAYLAR (cariprazine) PR Newswire
07:50AM  David Tepper's big bet in pharma
07:25AM  Are Hedge Funds Turning Bearish on Healthcare Stocks? at Insider Monkey
06:24AM  Logitech: Cramer's Top Takeaways
06:15AM  Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)
Mar-07-17 03:30PM  Fred's adds three industry veterans to board at bizjournals.com
12:38PM  Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan
Mar-06-17 02:35PM  Jeff Auxier Invests in Gilead, Wells Fargo, Apple
Mar-05-17 07:22AM  Billionaires Love These 3 Healthcare Stocks at Motley Fool
Mar-04-17 07:25PM  Icahn's (Potential) Move Into Biotech
Mar-03-17 07:13PM  FDA approves first drug to limit frequent waking to urinate
04:05PM  Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL PR Newswire
Mar-02-17 02:11PM  The Best Dividend Investors Are Preparing For Higher Interest Rates at Forbes
01:04PM  ALLERGAN PLC Financials
09:59AM  The eyes have it in Allergan's new ad campaign from FCB Chicago at bizjournals.com
08:00AM  Allergan to Present at the Barclays Global Healthcare Conference PR Newswire
Mar-01-17 06:58PM  Cramer Remix: Investors are too negative about fast-growi...
06:47PM  Could pharma sector roar even higher? Cramer checks the c...
06:42PM  Cramers charts uncover 4 pharma stocks ready to explode ...
06:36PM  Cramers charts uncover 4 pharma stocks ready to explode higher at CNBC
06:08PM  Jerome Dodson Adds to 9 Positions in 4th Quarter
07:35AM  Analyzing Pfizers Estimates for the Future
Feb-28-17 11:24AM  Big Money Still Long Valeant
Feb-27-17 05:12PM  Drugmakers pledge restraint, but prices will still soar
04:30PM  Allergan to Present at Raymond James 38th Annual Institutional Investors Conference PR Newswire
04:30PM  Allergan to Present at Cowen and Company 37th Annual Health Care Conference PR Newswire
01:23PM  Jim Cramer Is Passing on Valeant Ahead of Earnings
12:48PM  Johnson & Johnson reveals 3.5% net hike in drug pricing l...
09:30AM  The Zacks Analyst Blog Highlights: IBM, Allergan, Chubb, DISH Network and HP
09:06AM  Eli Lilly & Co.s Oncology Franchise
08:00AM  Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan PR Newswire
07:30AM  Allergan's New Eyepowerment Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action PR Newswire
06:00AM  Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia
01:51AM  Facing Criticism, Drug Makers Keep Lid On Price Increases at The Wall Street Journal
Feb-26-17 08:03PM  Drug Companies Keep Lid on Price Increases at The Wall Street Journal
12:28PM  Insider Q&A: Allergan CEO on impact of limiting price hikes
Feb-24-17 05:13PM  ALLERGAN PLC Files SEC form 10-K, Annual Report
01:21PM  NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes
10:58AM  Top Research Reports for February 24, 2017
Feb-23-17 05:15PM  Eli Lilly & Co.s Revenues in 4Q16
09:41AM  Pernix Therapeutics surges 42% after patent case win against generic from Actavis Labs at MarketWatch
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
NSC Norfolk Southern Corporation daily Stock Chart
NSC [NYSE]
Norfolk Southern Corporation
IndexS&P 500 P/E20.03 EPS (ttm)5.58 Insider Own0.10% Shs Outstand290.55M Perf Week-4.88%
Market Cap32.47B Forward P/E16.28 EPS next Y6.86 Insider Trans-27.36% Shs Float289.59M Perf Month-9.52%
Income1.66B PEG1.68 EPS next Q1.33 Inst Own71.20% Short Float1.34% Perf Quarter5.07%
Sales9.89B P/S3.28 EPS this Y10.30% Inst Trans0.32% Short Ratio1.82 Perf Half Y23.02%
Book/sh41.71 P/B2.68 EPS next Y11.61% ROA4.80% Target Price119.29 Perf Year35.94%
Cash/sh3.29 P/C33.97 EPS next 5Y11.89% ROE13.50% 52W Range76.22 - 125.00 Perf YTD3.96%
Dividend2.44 P/FCF71.85 EPS past 5Y0.60% ROI9.50% 52W High-10.93% Beta1.33
Dividend %2.18% Quick Ratio0.90 Sales past 5Y-2.40% Gross Margin44.60% 52W Low46.08% ATR2.10
Employees28044 Current Ratio1.00 Sales Q/Q-1.10% Oper. Margin31.10% RSI (14)26.70 Volatility2.10% 1.73%
OptionableYes Debt/Eq0.82 EPS Q/Q15.70% Profit Margin16.80% Rel Volume1.08 Prev Close111.77
ShortableYes LT Debt/Eq0.77 EarningsApr 26 BMO Payout41.90% Avg Volume2.13M Price111.34
Recom2.60 SMA20-6.33% SMA50-5.76% SMA20011.33% Volume970,256 Change-0.38%
Mar-23-17Downgrade RBC Capital Mkts Sector Perform → Underperform $113
Mar-14-17Initiated Wells Fargo Outperform
Jan-26-17Reiterated Cowen Outperform $116 → $130
Jan-18-17Initiated Buckingham Research Neutral
Jan-10-17Downgrade CLSA Outperform → Underperform
Jan-09-17Downgrade Seaport Global Securities Buy → Neutral $101 → $106
Nov-02-16Upgrade Argus Hold → Buy
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-11-16Upgrade BofA/Merrill Neutral → Buy
Jun-03-16Resumed Morgan Stanley Underweight
May-19-16Initiated Credit Agricole Outperform
Apr-25-16Resumed JP Morgan Neutral
Apr-22-16Upgrade UBS Neutral → Buy $84 → $102
Apr-22-16Upgrade Credit Suisse Neutral → Outperform
Apr-22-16Reiterated Cowen Outperform $89 → $101
Apr-22-16Reiterated Barclays Equal Weight $88 → $90
Apr-13-16Resumed BofA/Merrill Neutral
Jan-28-16Upgrade Avondale Mkt Underperform → Mkt Perform
Jan-28-16Reiterated RBC Capital Mkts Sector Perform $84 → $74
Jan-28-16Reiterated Cowen Outperform $93 → $89
Mar-23-17 09:55AM  Cramer's Stop Trading: Love affair with rails running out...
09:05AM  How Did GWRs North American Carloads Trend in February 2017?
Mar-22-17 08:05AM  Norfolk Southern's 2016 Annual Report highlights commitments met to lower costs, increase profitability, improve service, and enhance shareholder value PR Newswire
07:36AM  Canadian Nationals Carload Growth Is Faster than Peer Average
Mar-21-17 09:07AM  Is NSCs Intermodal Volume Growth Keeping Pace with Peers?
07:37AM  How Norfolk Southerns Carloads Stacked Up against Peers
Mar-20-17 05:00PM  US and Canada Freight Rail Traffic Volumes Were in the Fast Lane
02:20PM  Norfolk Southern safety train begins 23-city tour to educate first responders PR Newswire
10:51AM  Norfolk Southern Corp. : NSC-US: Dividend Analysis : February 03rd, 2017 (record date) : By the numbers : March 20, 2017
Mar-16-17 09:06AM  Despite Coal Downfall, Canadian Nationals Carloads Kept Soaring
Mar-15-17 05:43PM  Rebounding Coal Bodes Well for Railroads: Here's Why
10:38AM  How Were CSXs Carload Volumes in Week Ended March 4?
09:15AM  For an Inflation Hedge, Jump Aboard This Railroad Monopoly
09:06AM  How Norfolk Southerns Intermodal Volumes Compare to Peers
07:37AM  These Commodities Boosted Norfolk Southerns Carloads
Mar-14-17 05:10PM  Which Rail Stock Should You Board? Breaking Down Wells Fargo's Initiations In The Sector
03:35PM  Northeast storm hits transport stocks
11:57AM  A Strategy That Beat the Bull Market
10:05AM  Analysts Chime in on Corning, Quest Diagnostics, Canadian Pacific, Norfolk Southern, and More at Insider Monkey
06:12AM  Coverage initiated on Norfolk Southern by Wells Fargo
Mar-13-17 06:00AM  An Ideal Investment for Long-Term Investors at Morningstar
Mar-09-17 06:17PM  CSX's new CEO eyes yard closures, truckers' market share Reuters
01:27PM  New CSX CEO eyes yard closures, truckers' market share to lift profits Reuters
Mar-08-17 04:55PM  Timothy Tierney named president and chief operating officer of Conrail PR Newswire
Mar-07-17 11:02AM  [$$] Miss the CSX Rally? Try Norfolk Southern at Barrons.com
10:36AM  This Drove Canadian Nationals Upward Momentum in Carloads
09:07AM  A Birds Eye View of CSXs Intermodal Volumes in the 8th Week
07:37AM  What Happened to CSXs Carloads in the 8th Week?
Mar-06-17 06:47PM  CSX reaches deal with hedge fund, hires new railroad CEO
04:05PM  Behind Norfolk Southerns Intermodal Volumes in the 8th Week
02:35PM  Where Norfolk Southerns Carloads Stand in the Industry Now
12:45PM  Canada and US Freight Rail Traffic Pulls ahead of Mexico
Feb-28-17 10:37AM  Looking at CSXs Intermodal Volumes in the 7th Week of 2017
09:08AM  Why Did CSXs Carloads Rise?
07:38AM  Comparing Norfolk Southerns Intermodal Volumes
Feb-27-17 05:35PM  Which Commodity Groups Boosted Norfolk Southerns Carloads?
Feb-22-17 09:06AM  Inside GWRs European Carload Rise in January
Feb-21-17 03:35PM  Inside Norfolk Southerns Intermodal Volumes in the 6th Week
02:06PM  How Higher Coal Volumes Are Lifting Up Norfolk Southern
Feb-16-17 04:15PM  Norfolk Southern to present at Barclays Industrial Select Conference PR Newswire
01:10PM  Is CSX Corporation Stock Gearing Up for Another Huge Year After a Fantastic 2016? at Motley Fool
Feb-15-17 07:00AM  Norfolk Southern's Wide Moat Remains on the Rails at Morningstar
Feb-14-17 11:38PM  CSX railroad wants shareholder vote on hedge fund's demands
02:00PM  Norfolk Southern opens new locomotive maintenance and repair shop in Chicago PR Newswire
Feb-13-17 10:36AM  Why Genesee and Wyomings European Revenue Fell in 4Q16
Feb-09-17 01:04PM  NORFOLK SOUTHERN CORP Financials
Feb-07-17 07:36AM  Why Did Norfolk Southerns Intermodal Volumes Rise?
Feb-06-17 06:06PM  Coal Volume Boosts Norfolk Southerns Carloads
04:05PM  Norfolk Southern to present at Stifel 2017 Transportation and Logistics Conference PR Newswire
12:33PM  NORFOLK SOUTHERN CORP Files SEC form 10-K, Annual Report
Feb-02-17 08:15AM  Post Earnings Coverage as Norfolk Southern's Q4 EPS Rose 18%; Beat Estimates Accesswire
Feb-01-17 08:15AM  Post Earnings Coverage as Kansas City Southern's Reported Q4 Results Accesswire
07:36AM  Which Commodities Boosted Canadian Nationals Carloads?
Jan-31-17 07:38AM  How Do Norfolk Southerns Intermodal Volumes Compare?
Jan-30-17 05:06PM  Why Norfolk Southerns Carloads Increased
09:06AM  Norfolk Southerns Recommendations: Why All the Holds?
07:37AM  NSCs Operating Margins in 4Q16: Why the Elevated Track?
Jan-27-17 04:01PM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
10:37AM  Why Norfolk Southerns Intermodal Revenues Rose in 4Q16
09:07AM  Why Norfolk Southerns General Merchandise Revenue Slid in 4Q16
07:38AM  Why Norfolk Southerns Coal Revenues Slumped in 4Q16
Jan-26-17 05:05PM  What Happened to Norfolk Southerns Revenues in 4Q16?
03:27PM  Inside Norfolk Southerns 4Q16 Earnings Beat
10:26AM  Norfolk Southern Corp. :NSC-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017
10:00AM  Norfolk Southern facilitated $4.0 billion in industrial investment along rail lines in 2016 PR Newswire
08:22AM  Norfolk Southern Beats on Strong Cost Discipline
Jan-25-17 04:15PM  Norfolk Southern sees higher 2017 volumes on coal comeback
03:10PM  CSX shareholder backs Harrison for CEO as activist swoops in
01:04PM  2 Top Railway Companies Raise Their Dividends at Investopedia
11:27AM  Norfolk Southern (NSC) Beats on Q4 Earnings, Misses Sales
11:11AM  Edited Transcript of NSC earnings conference call or presentation 25-Jan-17 1:45pm GMT
09:30AM  Norfolk Southern (NSC) Beats on Q4 Earnings
08:45AM  Norfolk Southern Corp Earnings Call scheduled for 8:45 am ET today
08:15AM  Post Earnings Coverage as Union Pacific's Q4 Results Beat Market Estimates Accesswire
08:11AM  Norfolk Southern tops 4Q profit forecasts
08:11AM  Norfolk Southern quarterly profit rises
08:02AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:00AM  Norfolk Southern reports fourth-quarter and full-year 2016 results PR Newswire
07:07AM  Q4 2016 Norfolk Southern Corp Earnings Release - 08:00 am ET
04:20AM  European Stocks Books Solid Gains as Earnings, Deal Speculation Boost Sentiment
Jan-24-17 04:59PM  Norfolk Southern names six to vice president responsibilities PR Newswire
04:33PM  /C O R R E C T I O N -- Norfolk Southern Corporation/ PR Newswire
11:49AM  Why CSX Isn't The Only M&A Target In The Rail Space Right Now
Jan-23-17 10:37AM  How Do Norfolk Southerns Intermodal Volumes Compare?
09:08AM  Comparing Norfolk Southerns Carloads
08:25AM  'Dominating the discussion:' Analysts dig into CSX in wake of railroad legend's interest at bizjournals.com
07:39AM  US and Canadian Freight Rail Traffic Up, Mexican Traffic Down
Jan-20-17 07:38AM  Why CSXs Merchandise Revenue Rose in 4Q16
12:19AM  [$$] CSX Investors Cheered by Former Rail Rivals Sudden Switch at The Wall Street Journal
Jan-19-17 07:32PM  [$$] Railroad Maverick Buoys CSX Investors at The Wall Street Journal
04:53PM  The Hot Stock: CSX Surges 23% at Barrons.com
04:14PM  CSX shares explode on activist expectations
04:12PM  CSX Jumps As Outgoing Canadian Pacific CEO Reportedly Eyes Shakeup
03:21PM  Former CP CEO teaming with investor to target CSX railroad
02:42PM  [$$] CSX shares soar as rail industry veteran takes aim at Financial Times
11:07AM  All Aboard the CSX Activist Train at Bloomberg
09:42AM  CSX Surges as Activists Said to Target Railroad for Overhaul at Bloomberg
09:11AM  Canadian Pacific CEO Exit: 'Never A Dull Moment In Calgary'
07:15AM  Canadian Pacific (CP) Down on Q4 Earnings & Revenue Miss
Jan-18-17 09:42PM  Railroad Vet Teams With Activist to Target CSX
Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods in the United States. It also transports overseas freight through various Atlantic and Gulf Coast ports. In addition, the company is involved in the operation of scheduled passenger trains; leasing or sale of rail property and equipment; development of commercial real estate; telecommunications; and the acquisition, leasing, and management of coal, oil, gas, and minerals, as well as the transport of automotive and industrial products. As of February 14, 2017, it operated approximately 19,500 route miles in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STEWART MARTA REVP-Finance and CFOFeb 21Sale124.432,331290,04616,156Feb 23 08:02 AM
Hurlbut Thomas EVice President and ControllerFeb 17Option Exercise56.182,836159,3189,877Feb 21 01:46 PM
Hurlbut Thomas EVice President and ControllerFeb 17Sale122.371,475180,4907,100Feb 21 01:46 PM
STEWART MARTA REVP-Finance and CFOFeb 13Option Exercise75.142,370178,08220,857Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 13Sale123.072,370291,67618,487Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 09Option Exercise62.752,607163,57621,094Feb 10 10:57 AM
STEWART MARTA REVP-Finance and CFOFeb 09Sale121.972,607317,97618,487Feb 10 10:57 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Option Exercise47.765,000238,80023,107Feb 08 09:02 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Sale119.135,934706,91716,337Feb 08 09:02 AM
STEWART MARTA REVP-Finance and CFOFeb 03Option Exercise47.762,907138,83821,394Feb 06 03:34 PM
Hurlbut Thomas EVice President and ControllerFeb 03Sale120.651,297156,4777,041Feb 06 03:34 PM
STEWART MARTA REVP-Finance and CFOFeb 03Sale120.502,907350,29418,487Feb 06 03:34 PM
BOWLES ERSKINE BDirectorFeb 02Sale119.120133,475Feb 06 03:34 PM
CARP DANIEL ADirectorFeb 02Sale119.120533,886Feb 06 03:34 PM
LOCKHART MICHAEL DDirectorFeb 02Sale119.120193,729Feb 06 03:34 PM
THOMPSON JOHN RDirectorFeb 02Sale119.120163,144Feb 06 03:34 PM
BUSH WESLEY GDirectorFeb 02Sale119.1211183,387Feb 07 11:36 AM
Hurlbut Thomas EVice President and ControllerFeb 01Option Exercise47.7660728,9908,945Feb 03 05:17 PM
Hurlbut Thomas EVice President and ControllerFeb 01Sale118.2660771,7848,338Feb 03 05:17 PM
Squires James AChairman, President and CEOJan 26Option Exercise35.6037,4171,332,11095,709Jan 30 04:30 PM
STEWART MARTA REVP-Finance and CFOJan 26Option Exercise0.00950020,898Jan 30 04:32 PM
Wheeler Michael JosephEVP & Chief Operating OfficerJan 26Option Exercise0.00950012,046Jan 30 04:32 PM
Earhart Cynthia CExec. VP - Admin. and CIOJan 26Option Exercise0.0095005,813Jan 30 04:30 PM
Galanko William AndrewSVP - Law and Corp. Comm.Jan 26Option Exercise0.00950018,848Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerJan 26Option Exercise0.0095009,083Jan 30 04:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerJan 26Option Exercise0.0055004,264Jan 30 04:30 PM
Squires James AChairman, President and CEOJan 26Sale119.7734,4174,122,29354,589Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerNov 18Sale103.7746948,6677,041Nov 21 03:03 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Option Exercise47.762,700128,9524,759Nov 18 03:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Sale103.171,654170,6402,622Nov 18 03:30 PM
Squires James AChairman, President and CEONov 11Option Exercise42.764,676199,93749,643Nov 14 10:41 AM
STEWART MARTA REVP-Finance and CFONov 11Sale100.901,970198,7739,774Nov 14 10:15 AM
STEWART MARTA REVP-Finance and CFONov 10Sale100.082,017201,86111,744Nov 14 10:15 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Option Exercise38.7114,417558,010136,234Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Option Exercise38.714,417170,9604,417Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Sale97.0014,4171,398,449121,817Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Sale99.004,417437,2980Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Option Exercise38.7110,000387,050142,647Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Option Exercise50.744,530229,8524,530Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Sale96.184,530435,6730Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Sale95.4820,8301,988,850121,817Nov 10 09:45 AM
STEWART MARTA REVP-Finance and CFONov 07Sale94.102,023190,3647,824Nov 08 03:43 PM
Hurlbut Thomas EVice President and ControllerNov 07Sale94.461,00094,4617,560Nov 08 03:44 PM
Hurlbut Thomas EVice President and ControllerOct 27Sale91.212,170197,9208,560Oct 28 04:43 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 03Option Exercise59.785,016299,851132,647Oct 04 04:26 PM
STEWART MARTA REVP-Finance and CFOSep 19Option Exercise75.141,33099,93612,127Sep 20 01:58 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Option Exercise38.718,557331,199136,188Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Sale94.158,557805,642127,631Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Option Exercise38.711,44355,851129,074Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Sale94.161,443135,866127,631Aug 31 11:43 AM
STEWART MARTA REVP-Finance and CFOAug 25Option Exercise62.751,59399,95310,797Aug 29 10:36 AM
Hurlbut Thomas EVice President and ControllerAug 24Sale92.2885078,43810,730Aug 25 02:30 PM
STEWART MARTA REVP-Finance and CFOAug 19Sale91.541,562142,9859,204Aug 19 03:48 PM
STEWART MARTA REVP-Finance and CFOAug 18Sale91.581,502137,55310,766Aug 19 03:48 PM
Hurlbut Thomas EVice President and ControllerAug 17Option Exercise38.711,01739,36312,597Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 17Sale89.301,01790,81811,580Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 03Sale88.3552846,64711,580Aug 04 11:59 AM
Hurlbut Thomas EVice President and ControllerMay 05Sale89.9266860,07012,203May 06 02:24 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Option Exercise49.566,500322,1086,500Apr 26 04:51 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Sale90.046,500585,2480Apr 26 04:51 PM
Wheeler Michael JosephEVP & Chief Operating OfficerApr 22Option Exercise57.562,436140,21411,715Apr 26 10:50 AM
AET Aetna Inc. daily Stock Chart
AET [NYSE]
Aetna Inc.
IndexS&P 500 P/E20.01 EPS (ttm)6.41 Insider Own0.20% Shs Outstand350.90M Perf Week-4.31%
Market Cap45.03B Forward P/E13.09 EPS next Y9.80 Insider Trans-9.15% Shs Float348.85M Perf Month1.58%
Income2.27B PEG1.46 EPS next Q2.35 Inst Own92.70% Short Float4.50% Perf Quarter3.62%
Sales63.16B P/S0.71 EPS this Y-5.50% Inst Trans0.53% Short Ratio5.18 Perf Half Y12.42%
Book/sh50.81 P/B2.53 EPS next Y10.63% ROA3.40% Target Price138.25 Perf Year15.04%
Cash/sh51.29 P/C2.50 EPS next 5Y13.74% ROE12.90% 52W Range104.38 - 136.22 Perf YTD3.69%
Dividend2.00 P/FCF14.54 EPS past 5Y4.20% ROI7.40% 52W High-5.30% Beta0.59
Dividend %1.56% Quick Ratio- Sales past 5Y13.30% Gross Margin- 52W Low23.60% ATR1.94
Employees49500 Current Ratio- Sales Q/Q4.50% Oper. Margin7.30% RSI (14)50.64 Volatility1.46% 1.29%
OptionableYes Debt/Eq1.16 EPS Q/Q-56.90% Profit Margin3.60% Rel Volume0.64 Prev Close128.33
ShortableYes LT Debt/Eq1.06 EarningsJan 31 BMO Payout15.50% Avg Volume3.03M Price129.01
Recom2.30 SMA20-1.43% SMA502.75% SMA2007.31% Volume819,769 Change0.53%
Jan-24-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-04-17Initiated Piper Jaffray Neutral
Nov-14-16Downgrade Bernstein Outperform → Mkt Perform
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Jun-16-16Initiated Bernstein Outperform
Apr-29-16Reiterated RBC Capital Mkts Outperform $140 → $144
Feb-02-16Reiterated Wedbush Neutral $130 → $120
Feb-02-16Reiterated RBC Capital Mkts Outperform $142 → $140
Jan-08-16Downgrade Jefferies Buy → Hold
Dec-16-15Initiated Credit Suisse Neutral
Sep-18-15Upgrade Cantor Fitzgerald Hold → Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $159 → $162
Jul-30-15Upgrade BofA/Merrill Neutral → Buy $132
Jul-06-15Downgrade FBR Capital Outperform → Mkt Perform $130
Jun-26-15Reiterated Leerink Partners Outperform $145 → $150
Jun-24-15Initiated RBC Capital Mkts Sector Perform $159
Jun-17-15Reiterated Leerink Partners Outperform $135 → $145
May-12-15Reiterated Leerink Partners Outperform $130 → $135
Apr-29-15Reiterated Argus Buy $115 → $130
Mar-22-17 06:11PM  Molina Hit by Public Exchanges, Failed Aetna-Humana Merger
04:30PM  Hospital, Medicaid insurer shares set for volatility as health vote nears Reuters
11:00AM  How Mobile Apps Reduce Follow-Up Visits After Surgery at Forbes
07:15AM  Health care stocks under GOP plan
Mar-21-17 04:28PM  AETNA INC /PA/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat
03:53PM  Health Insurance Lobby Backs Trumpcare Revisions at Forbes
10:14AM  AET INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 GlobeNewswire
09:35AM  Should Value Investors Consider Aetna (AET) Stock?
Mar-20-17 09:56PM  [$$] White House Set to Announce Head of Senate Legislative Affairs Team at The Wall Street Journal
11:01AM  SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-19-17 09:31AM  U.S. Republicans working on Medicaid, tax credit changes-Ryan Reuters
Mar-18-17 02:22PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Aetna Inc. to Contact the Firm Before Imminent Lead Plaintiff Deadline Accesswire
01:00PM  Obamacare Repeal to Cut Deficit, but Greatly Expand Ranks of Uninsured
Mar-17-17 05:43PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aetna Inc. -- AET PR Newswire
03:02PM  Justice Department Probing Health Insurers Over Medicare Fraud Allegations
01:06PM  U.S. probing insurers beyond UnitedHealth over Medicare charges Reuters
11:45AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 AET GlobeNewswire
11:25AM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-16-17 12:13PM  Obamacare Repeal Takes Another Step but GOP Showdown Looms
10:30AM  Investor Alert: GPM Reminds Investors of the March 27 Deadline in the Class Action Lawsuit Against Aetna Inc. Business Wire
Mar-15-17 04:56PM  Rep. Garrett: Good things in GOP health bill, but there a...
Mar-14-17 04:16PM  AETNA INC /PA/ Files SEC form 8-K, Regulation FD Disclosure
02:57PM  Humana selling bonds to raise $1 billion at bizjournals.com
01:49PM  Republicans on defense after report shows millions would lose insurance Reuters
11:45AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) and Lead Plaintiff Deadline - March 27, 2017 Accesswire
Mar-13-17 02:29PM  Aetna: A Bullish Setup for Aggressive Traders
12:12PM  Humana Inc. -- Moody's rates Humana's senior notes Baa3; outlook stable at Moody's
10:37AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 Business Wire
10:28AM  Aetna, Inc. :AET-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017
Mar-12-17 08:02PM  Health law's woes, real or perceived, drive call for repeal
Mar-10-17 04:21PM  Brookings: 15M could lose health care coverage with new p...
01:32PM  Aetna, Inc. :AET-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017
10:18AM  House leader: 'very difficult' to speed up end to Medicaid expansion Reuters
Mar-09-17 12:19PM  Trumpcare Won't Make Health Insurers Sick at The Wall Street Journal
Mar-08-17 01:40PM  Democrats fight Trump-backed U.S. healthcare plan, Ryan defends it Reuters
11:59AM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:34AM  AET SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 Business Wire
09:40AM  House panels to launch fight in Congress over Obamacare replacement Reuters
Mar-07-17 05:50PM  Conservatives rebel against Trump-backed Republican healthcare plan Reuters
01:09PM  Today's charts: Aetna, Humana, Cigna and Anthem on the move after new GOP health care bill
11:14AM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:22AM  Healthcare stocks slide after the GOP releases its plan to repeal Obamacare
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) and Lead Plaintiff Deadline: March 27, 2017 Accesswire
07:54AM  Early movers: DKS, MIK, NAV, PFE, AET, CSX, & more at CNBC
06:31AM  What's working: Health care stocks after Obamacare
Mar-06-17 03:32PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-05-17 09:02AM  Rift Widens, Fractures Grow Among Republicans On Obamacare at Forbes
Mar-03-17 02:06PM  Aetna, Inc. : AET-US: Dividend Analysis : January 12th, 2017 (record date) : By the numbers : March 3, 2017
Mar-02-17 06:06PM  AET NOTICE: Rosen Law Firm Reminds Aetna Inc. Investors of Important Deadline in Class Action AET GlobeNewswire
05:00PM  Aetna Executive to Present at Barclays Global Healthcare Conference Business Wire
Mar-01-17 04:42PM  Connecticut says will not drop opposition to Anthem/Cigna deal Reuters
12:46PM  Infrastructure, Immigration And 7 Key Takeaways From Trump's Address To Congress
Feb-28-17 03:32PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) and Lead Plaintiff Deadline: March 27, 2017 Accesswire
Feb-27-17 06:04PM  [$$] Texas Hospital Files for Bankruptcy Amid Aetna Dispute at The Wall Street Journal
04:16PM  AETNA INC /PA/ Files SEC form 8-K, Other Events
01:28PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
01:05PM  Lawsuit for Investors in NYSE:AET shares against Aetna Inc announced by Shareholders Foundation GlobeNewswire
11:44AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 AET Business Wire
11:32AM  Trump meets insurers, promises catastrophic year for Obamacare Reuters
10:47AM  INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:23AM  Buffett's big bite of Apple, Trump's meeting with health insurance CEOs and Oscar's big goof
08:00AM  Aetna Announces Full Redemption of 3.95 Percent Senior Notes Due September 1, 2020 Business Wire
01:48AM  [$$] Health Insurers Hope for Nothing at The Wall Street Journal
Feb-26-17 01:14PM  [$$] Health Insurers Hope for Nothing at The Wall Street Journal
06:00AM  DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Aetna Inc. To Contact The Firm Business Wire
Feb-24-17 04:33PM  [$$] Trump to Meet With Insurance Executives on Repeal of Affordable Care Act at The Wall Street Journal
02:09PM  Affordable Care Act Replacement Bill Leaked
Feb-23-17 05:04PM  5 Things Republicans Want To Change About Obamacare But Might Not Be Able To
01:04PM  AETNA INC /PA/ Financials
Feb-22-17 05:15PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:19PM  AETNA INC /PA/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat
11:36AM  Trump, House Republicans Seek Delay In Healthcare Ruling - Because They're Afraid They'll Win
11:06AM  AET SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017 Business Wire
09:59AM  Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem?
08:50AM  Health insurer Aetna to spend $3.3B buying back stock
07:59AM  Aetna Announces $3.3 Billion Share Repurchase Program
07:51AM  Aetna enters $3.3 billion accelerated share buyback program at MarketWatch
07:45AM  Aetna Announces $3.3 Billion Accelerated Share Repurchase Business Wire
Feb-21-17 01:45PM  Hedge Funds Bought Financial, Health Care Stocks in Q4
12:32PM  Finding the Bullish and Bearish Reversals
10:48AM  SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) & Lead Plaintiff Deadline: March 27, 2017 GlobeNewswire
10:00AM  Here's a Quick Look At the Heavy Hitters That Struggling Tiffany & Co. Just Added to its Board
08:39AM  Community Health Systems (CYH) Q4 Earnings Beat Estimates
Feb-20-17 06:31PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:03PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aetna Inc. To Contact The Firm Before Lead Plaintiff Deadline PR Newswire
Feb-19-17 05:03PM  Obamacare was 'flawed', but here's what health care should look like after reform: ex-Aetna CEO at CNBC
Feb-18-17 01:25AM  [$$] Baird Sticks With Its Wal-Mart Rating and Target Price at Barrons.com
01:24AM  [$$] Merger's Collapse Could Boost Anthem Stock at Barrons.com
Feb-17-17 05:42PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
05:11PM  Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and The Western Union Company PR Newswire
04:52PM  Aetna Shares Bounce Back After Close
04:43PM  Aetna Doubles Its Dividend, Adds to Stock Buyback at Investopedia
04:33PM  AETNA INC /PA/ Files SEC form 10-K, Annual Report
04:11PM  Aetna fattens shareholder payout after Humana deal fails
03:34PM  [$$] Aetna Doubles Dividend, Boosts Buyback Plans at The Wall Street Journal
03:31PM  Moody's Jumps into Action as Aetna-Humana Deal Fails
03:20PM  DOJ: UnitedHealth improperly overcharged medicare
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products, including pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SOISTMAN FRANCIS S JRExec. VP, Government ServicesMar 08Sale131.986,607872,02023,454Mar 10 04:09 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesMar 06Option Exercise72.6054,8333,980,87671,680Mar 07 05:47 PM
McCarthy Margaret MEVP, Operations & TechnologyFeb 22Sale128.877,9301,021,91148,310Feb 24 04:31 PM
Bertolini Mark TChairman and CEOFeb 03Option Exercise42.57148,1386,306,235391,808Feb 07 04:27 PM
Coye Molly JoelDirectorNov 30Sale131.171,145150,1877,517Dec 02 05:11 PM
Lynch Karen SPresidentNov 11Sale119.5545,0005,379,92651,254Nov 15 04:06 PM
Coye Molly JoelDirectorNov 09Sale116.96862100,8208,662Nov 14 05:33 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesNov 07Sale109.789,1501,004,47812,367Nov 09 04:14 PM
GARTEN JEFFREY EDirectorSep 07Sale116.517,100827,2149,398Sep 09 04:12 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 23Sale120.318,140979,32344,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Option Exercise72.2640,0002,890,40084,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Sale120.1937,1884,469,74844,883Aug 24 04:32 PM
McCarthy Margaret MEVP, Operations & TechnologyMay 10Sale114.4539,1694,483,01056,240May 12 06:06 PM
Bertolini Mark TChairman and CEOMay 03Sale114.0033,5103,820,157390,018May 04 04:20 PM
Bertolini Mark TChairman and CEOMay 02Option Exercise39.93106,5704,255,340496,588May 04 04:20 PM
SRE Sempra Energy daily Stock Chart
SRE [NYSE]
Sempra Energy
IndexS&P 500 P/E20.48 EPS (ttm)5.47 Insider Own0.10% Shs Outstand250.54M Perf Week1.39%
Market Cap28.05B Forward P/E19.56 EPS next Y5.72 Insider Trans-27.52% Shs Float250.20M Perf Month5.92%
Income1.37B PEG3.20 EPS next Q1.61 Inst Own83.80% Short Float2.10% Perf Quarter9.76%
Sales10.20B P/S2.75 EPS this Y1.50% Inst Trans0.05% Short Ratio5.91 Perf Half Y5.52%
Book/sh51.67 P/B2.17 EPS next Y11.67% ROA3.10% Target Price117.14 Perf Year12.11%
Cash/sh1.39 P/C80.36 EPS next 5Y6.40% ROE11.20% 52W Range91.57 - 112.57 Perf YTD12.06%
Dividend3.29 P/FCF- EPS past 5Y-0.20% ROI3.90% 52W High0.13% Beta0.50
Dividend %2.94% Quick Ratio0.50 Sales past 5Y0.30% Gross Margin96.80% 52W Low23.09% ATR1.53
Employees16575 Current Ratio0.50 Sales Q/Q8.20% Oper. Margin15.30% RSI (14)69.88 Volatility1.45% 1.36%
OptionableYes Debt/Eq1.32 EPS Q/Q3.10% Profit Margin13.40% Rel Volume0.76 Prev Close111.94
ShortableYes LT Debt/Eq1.11 EarningsFeb 28 BMO Payout54.20% Avg Volume890.34K Price112.72
Recom2.00 SMA203.33% SMA507.25% SMA2008.23% Volume282,729 Change0.70%
Feb-29-16Reiterated Barclays Overweight $111 → $110
Jan-25-16Reiterated RBC Capital Mkts Outperform $119 → $116
May-06-15Reiterated Barclays Overweight $117 → $120
Sep-22-14Reiterated RBC Capital Mkts Outperform $106 → $115
Aug-14-14Reiterated UBS Buy $106 → $111
Apr-14-14Initiated UBS Buy $106
Apr-02-14Reiterated RBC Capital Mkts Outperform $102 → $104
Jan-06-14Reiterated Barclays Overweight $101 → $97
May-28-13Upgrade Barclays Equal Weight → Overweight $85 → $90
Apr-24-13Reiterated Barclays Equal Weight $77 → $85
Apr-23-13Downgrade ISI Group Buy → Neutral
Feb-27-13Reiterated Barclays Equal Weight $70 → $77
Jan-07-13Upgrade ISI Group Neutral → Buy
Jul-23-12Downgrade Argus Buy → Hold
Apr-03-12Reiterated Barclays Equal Weight $60 → $63
Nov-07-11Reiterated RBC Capital Mkts Sector Perform $54 → $57
Jun-24-11Initiated RBC Capital Mkts Sector Perform $55
Apr-08-11Reiterated Barclays Capital Equal Weight $54 → $57
Feb-28-11Downgrade Barclays Capital Overweight → Equal Weight $57 → $55
Dec-10-10Initiated Oppenheimer Perform $56
Mar-22-17 09:00AM  Sempra Energy To Webcast Analyst Conference April 5 PR Newswire
Mar-20-17 11:22AM  Sempra Energy Stock Trades Ex-Dividend Tuesday at Investopedia
Mar-16-17 04:42PM  SDG&E Spurs Energy Storage Innovation With Flow Battery Technology PR Newswire
Mar-15-17 07:37AM  Sempra Energys Dividend Profile, Inside Out
Mar-14-17 06:05PM  These Big Utilities Are Paying Higher Dividends Now
04:14PM  Sempras Long-Term Dividend Growth: What Its Position?
04:14PM  Sempra Energys Dividend: Why the Low Yield?
04:14PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
10:12AM  SoCalGas Joins Gold Shovel Standard to Improve Excavation Safety and Reduce Pipeline Damage PR Newswire
08:15AM  Post Earnings Coverage as Public Service Enterprise's Adjusted EPS Grew 8% Accesswire
07:00AM  Sempra Energy Appoints Contreras-Sweet To Board Of Directors PR Newswire
Mar-07-17 11:00AM  P. Kevin Chase Appointed Chief Information Officer For Sempra Energy PR Newswire
Mar-06-17 12:17AM  [$$] How California Utilities Are Managing Excess Solar Power at The Wall Street Journal
Mar-04-17 01:04PM  SEMPRA ENERGY Financials
07:30AM  [$$] How California Utilities Are Managing Excess Solar Power at The Wall Street Journal
07:00AM  How California Utilities Are Managing Excess Solar Power
Mar-02-17 09:18AM  Sempra Energy :SRE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017
Mar-01-17 11:17AM  Sempra Energy :SRE-US: Earnings Analysis: 2016 By the Numbers : March 1, 2017
09:28AM  Maxwell (MXWL) Q4 Loss Wider than Expected, Revenues Beat
09:26AM  Sempra Energy Puts Some Major Issues to Bed in the Fourth Quarter at Motley Fool
01:00AM  U.S. military marches forward on green energy, despite Trump Reuters
Feb-28-17 11:18PM  Edited Transcript of SRE earnings conference call or presentation 28-Feb-17 5:00pm GMT
04:43PM  Sempra Energy Appoints Two New Directors PR Newswire
12:23PM  Sempra Energy (SRE) Beats on Q4 Earnings, Lifts '17 View
11:38AM  SEMPRA ENERGY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
10:11AM  [$$] Sempra Energy Increases Earnings Guidance at The Wall Street Journal
09:46AM  Sempra Energy (SRE) Tops Q4 Earnings, Misses on Revenues
08:51AM  Sempra beats 4Q profit forecasts
08:30AM  Sempra Energy Announces 2016 Earnings PR Newswire
07:07AM  Q4 2016 Sempra Energy Earnings Release - 08:30 am ET
Feb-27-17 04:20PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
11:49AM  14 Dividend Stocks Rewarding Shareholders With A Raise at Insider Monkey
Feb-24-17 09:00AM  SDG&E Unveils World's Largest Lithium Ion Battery Energy Storage Facility PR Newswire
06:58AM  Will Sempra Energy (SRE) Upset Investors in Q4 Earnings?
Feb-23-17 01:41PM  Sempra Energy Raises Annualized Dividend By 9 Percent PR Newswire
Feb-16-17 02:30PM  SoCalGas to Install up to 60 New Valves in 2017 to Enhance Pipeline System Safety PR Newswire
Feb-15-17 03:15PM  Sempra Energy : SRE-US: Dividend Analysis : December 29th, 2016 (record date) : By the numbers : February 15, 2017
Feb-14-17 09:00AM  Sempra Energy To Report Fourth-Quarter 2016 Earnings Feb. 28 PR Newswire
Feb-13-17 04:41PM  SoCalGas to Feature Biogas Technology and Powerful New Compressed Natural Gas Big Rigs at 50th Annual World Agricultural Expo PR Newswire
Feb-10-17 01:06PM  SoCalGas Declares Preferred Dividends PR Newswire
Feb-09-17 03:02PM  SoCalGas Pilot Biogas Project Selected by U.S. Energy Department for Funding PR Newswire
Feb-08-17 06:05PM  What Analysts Think about PG&E ahead of 4Q16 Earnings
Feb-07-17 04:48PM  Sempra Energy Announces California Utilities' Settlement Agreement For Two-Year Extension Of Cost-Of-Capital Application PR Newswire
04:45PM  SEMPRA ENERGY Files SEC form 8-K, Other Events
Feb-06-17 12:46PM  TransCanada Corporation's 3 Biggest Growth Opportunities at Motley Fool
Feb-02-17 12:05PM  Utility Stocks: Analyzing Returns and Implied Volatilities
10:18AM  Why Is NRG Energys Implied Volatility Up?
Feb-01-17 08:05AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : February 1, 2017
Jan-31-17 03:46PM  SoCalGas and CR&R Environmental Announce Construction of Pipeline to Provide Carbon-Neutral Renewable Natural Gas PR Newswire
Jan-30-17 04:21PM  Sempra to Use Moon-Mission Technology to Back Up Substations at Bloomberg
03:05PM  SoCalGas Offers Tips on Reducing Winter Gas Bills PR Newswire
Jan-26-17 05:50PM  SoCalGas Advisory Lifted PR Newswire
Jan-25-17 01:44PM  SoCalGas says stops natgas withdrawal from Aliso Canyon storage facility
Jan-24-17 05:01PM  SoCalGas says ceases natgas withdrawal from Aliso Canyon storage facility
Jan-23-17 05:15PM  California utilities seek $1 bln for vehicle electrification Reuters
09:45AM  SoCalGas Advisory Now in Effect PR Newswire
Jan-22-17 04:41PM  SoCalGas Announces "SoCalGas Advisory" PR Newswire
Jan-20-17 08:43PM  SDG&E Aims To Reduce Air Pollution By Deploying Electric Vehicle Charging Throughout The Community PR Newswire
Jan-17-17 09:28PM  SoCalGas Statement on California Department of Conservation's Division of Oil, Gas and Geothermal Resources Announcement of Public Meeting PR Newswire
06:46PM  California moves toward reopening Aliso Canyon gas storage field Reuters
04:18PM  California to hold public meeting on Aliso Canyon natgas facility Reuters
Jan-16-17 10:03AM  Mexico's IEnova will invest $800 mln in 2017 on 8 projects - CEO
Jan-11-17 02:42PM  SoCalGas Announces Funding for Demonstration of Mobile CNG Refueling Solution Developed by Onboard Dynamics, Inc. PR Newswire
Jan-10-17 06:03PM  SoCalGas to Use Fiber Optic Technology to Monitor Pipelines in Real Time PR Newswire
10:10AM  Houston area dominates list of best energy cos. to work for in the U.S. at bizjournals.com
Jan-03-17 04:36PM  SDG&E President, Scott D. Drury, Begins Role PR Newswire
Dec-30-16 07:37AM  SRE, EIX, and PCG: Analyzing Utilities Current Valuations
Dec-29-16 09:08AM  Whats Next for Sempra Energy Stock?
07:37AM  Analysts Expect a Handsome Upside for Sempra Energy in 2017
Dec-28-16 07:50AM  Sempra Energy breached its 50 day moving average in a Bearish Manner : SRE-US : December 28, 2016
Dec-20-16 03:29PM  SoCalGas Lifts "SoCalGas Advisory" PR Newswire
Dec-19-16 02:14PM  SDG&E Urges Customers To Be On "High Alert" For Scam Artists PR Newswire
08:29AM  Sempra Energy (SRE) Unit Buys Ventika Facility in Mexico
Dec-18-16 08:59PM  SoCalGas Issues "SoCalGas Advisory" PR Newswire
Dec-16-16 01:07PM  Sempra Energy Declares Common Dividend PR Newswire
Dec-15-16 06:24PM  Sempra Energy Unit IEnova Completes Acquisition Of Ventika Wind Generation Facilities In Mexico PR Newswire
04:43PM  SDG&E To Upgrade Infrastructure In Orange County To Improve Reliability And Public Safety PR Newswire
12:33PM  SoCalGas Completes More than 700,000 Safety Checks in First Year of Meter Inspection Program PR Newswire
Dec-14-16 06:38PM  SDG&E Transforming Vehicle Fleet PR Newswire
02:23PM  MIT Wins Peeptrade's Global Investment Challenge
11:13AM  Sempra Energy Value Analysis (NYSE:SRE) : December 14, 2016
Dec-13-16 07:26AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : December 13, 2016
Dec-08-16 08:46AM  Hedge Funds Are Selling Sempra Energy (SRE) at Insider Monkey
Dec-06-16 03:17PM  Clean Energy Milestone: 100,000th Private Solar Array Connected To SDG&E's Power Grid PR Newswire
03:09PM  In a National First, SoCalGas and University of California Irvine Successfully Test Innovative Technology that Stores Renewable Energy PR Newswire
Dec-04-16 11:57AM  Weekly Top Insider Buys Highlight for the Week of Dec. 2
Dec-01-16 04:25PM  Calif. expects to complete Aliso Canyon natgas review in early 2017 Reuters
Nov-30-16 05:41PM  SoCalGas Announces "SoCalGas Advisory" Conservation Notification Program to Reduce Risk of Natural Gas Shortages This Winter PR Newswire
02:37PM  SoCalGas Declares Preferred Dividends PR Newswire
01:39PM  Heavy Insider Selling at Invesco Ltd. (IVZ) and Las Vegas Sands Corp. (LVS), Plus Insider Buying at 3 Other Companies at Insider Monkey
Nov-29-16 07:55PM  Port Arthur LNG Files Federal Application To Construct Natural Gas Liquefaction And Export Facilities In Texas PR Newswire
Nov-23-16 09:17PM  Sempra quits talks on Odebrecht Peru pipeline, partners scramble
06:03PM  Sempra drops bid for Odebrecht pipeline in Peru, Techint in talks
04:36PM  Media Statement On Peru Pipeline PR Newswire
03:31PM  Techint says still in talks to buy Odebrecht Peru pipeline stake
Nov-19-16 11:15AM  Peru eyes new auction for natgas pipeline contract in 2017-govt
Nov-18-16 02:10PM  Peru considers rescinding Odebrecht's pipeline contract -source
01:36AM  "Team SoCalGas" Sponsors 2016 United Way HomeWalk; Largest Participant With Over 1,300 Walkers And More Than $151,000 In Contributions PR Newswire
Nov-15-16 05:10PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
Nov-14-16 03:00PM  SoCalGas Deploys Sensors to Detect Methane and Enhance Public Safety PR Newswire
Sempra Energy, together with its subsidiaries, engages in energy business worldwide. The company's San Diego Gas & Electric Company segment transmits and distributes electricity and/or natural gas. As of December 31, 2016, this segment had approximately 1.4 million electric meters and 878,000 natural gas meters. Its Southern California Gas Company segment purchases, transports, sells, distributes, and stores natural gas. As of December 31, 2015, this segment had approximately 5.9 million customer meters. The company's Sempra South American Utilities segment provides electricity distribution services through 10,118 miles of distribution lines, 352 miles of transmission lines, and 48 substations located in the region of Valparaiso in central Chile, as well as through 13,763 miles of distribution lines, 194 miles of transmission lines, and 39 substations located in the Cusco region of Peru. Its Sempra Mexico segment owns, develops, and operates natural gas pipelines, ethane systems, and a liquid petroleum gas pipeline and associated storage terminals; electric generation facilities; natural gas distribution systems; and liquefied natural gas (LNG) regasification terminals. The company's Sempra Renewables segment is involved in the investment and development of wind and solar power generation facilities. Its Sempra LNG & Midstream segment invests in and develops LNG-related infrastructure in North America; develops and operates natural gas storage facilities in Alabama and Mississippi; and owns a liquefaction project in Louisiana. The company primarily serves residential, commercial, and industrial customers. Sempra Energy was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OUCHI WILLIAM GDirectorMar 06Option Exercise46.025,000230,10021,247Mar 06 03:34 PM
OUCHI WILLIAM GDirectorMar 06Sale108.925,000544,60016,247Mar 06 03:34 PM
RUTLEDGE WILLIAM PDirectorMar 02Option Exercise52.5910,000525,85015,846Mar 02 05:45 PM
OUCHI WILLIAM GDirectorMar 02Sale109.8760065,92216,247Mar 03 02:42 PM
RUTLEDGE WILLIAM PDirectorMar 02Sale109.6915,2621,674,089584Mar 02 05:45 PM
DAVIS STEVEN DCorp. Group PresidentFeb 13Sale105.002,233234,46520,567Feb 13 05:18 PM
HOUSEHOLDER JOSEPH ACorp. Group PresidentJan 24Sale102.106,472660,79147,425Jan 24 08:43 PM
REED DEBRA LChairman and CEOJan 23Sale102.3417,3001,770,482127,645Jan 23 07:20 PM
ROWLAND G JOYCESenior VPJan 19Sale102.592,862293,6131Jan 19 02:00 PM
Martin Jeffrey WExecutive VP and CFOJan 10Sale100.954,266430,6730Jan 10 01:57 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Option Exercise61.4112,000736,92059,425Dec 13 04:42 PM
SNELL MARK APresidentDec 12Sale103.0635,0003,607,10037,914Dec 13 04:41 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Sale102.6912,0001,232,28047,425Dec 13 04:42 PM
ROWLAND G JOYCESenior VPDec 08Sale99.1212512,3901Dec 09 04:11 PM
BOECKMANN ALAN LDirectorNov 29Buy101.526,000609,1166,000Nov 29 06:26 PM
MIHALIK TREVOR ISVP, Controller and CAOAug 10Sale106.865,659604,7212,615Aug 10 05:02 PM
RUTLEDGE WILLIAM PDirectorAug 08Option Exercise64.815,000324,05010,838Aug 08 07:52 PM
RUTLEDGE WILLIAM PDirectorAug 08Sale107.205,000536,0005,838Aug 08 07:52 PM
SNELL MARK APresidentMay 06Sale103.9950,0005,199,50072,909May 09 03:44 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E30.35 EPS (ttm)6.02 Insider Own0.30% Shs Outstand212.82M Perf Week-1.03%
Market Cap38.87B Forward P/E17.56 EPS next Y10.40 Insider Trans-7.90% Shs Float212.23M Perf Month0.74%
Income1.31B PEG2.99 EPS next Q2.24 Inst Own85.40% Short Float1.58% Perf Quarter9.97%
Sales12.42B P/S3.13 EPS this Y34.00% Inst Trans0.07% Short Ratio3.54 Perf Half Y4.72%
Book/sh35.59 P/B5.13 EPS next Y10.25% ROA5.10% Target Price189.07 Perf Year24.10%
Cash/sh4.40 P/C41.48 EPS next 5Y10.16% ROE16.90% 52W Range145.39 - 185.70 Perf YTD10.76%
Dividend2.92 P/FCF33.95 EPS past 5Y-3.30% ROI6.90% 52W High-0.62% Beta1.05
Dividend %1.60% Quick Ratio0.80 Sales past 5Y10.50% Gross Margin48.60% 52W Low26.93% ATR2.29
Employees50900 Current Ratio1.10 Sales Q/Q-2.10% Oper. Margin15.20% RSI (14)60.02 Volatility1.76% 1.18%
OptionableYes Debt/Eq1.45 EPS Q/Q143.80% Profit Margin10.50% Rel Volume1.14 Prev Close182.64
ShortableYes LT Debt/Eq1.19 EarningsFeb 02 BMO Payout44.10% Avg Volume948.20K Price184.55
Recom2.30 SMA200.66% SMA503.31% SMA2007.03% Volume453,535 Change1.05%
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-12-15Initiated Citigroup Neutral
Aug-19-15Reiterated Argus Buy $156 → $167
Aug-10-15Reiterated Deutsche Bank Hold $147 → $155
Aug-07-15Reiterated RBC Capital Mkts Sector Perform $150 → $162
Jul-02-15Resumed Barclays Equal Weight $158
Jun-29-15Upgrade UBS Neutral → Buy $159 → $167
Mar-24-15Reiterated Canaccord Genuity Hold $125 → $149
Mar-10-15Initiated UBS Neutral $159
Feb-11-15Reiterated Argus Buy $140 → $156
Feb-06-15Reiterated RBC Capital Mkts Outperform $145 → $150
Oct-08-14Reiterated RBC Capital Mkts Sector Perform $116 → $132
Oct-07-14Upgrade Stifel Hold → Buy $153
Oct-07-14Reiterated Canaccord Genuity Hold $113 → $125
Mar-19-17 11:12AM  Dividend Aristocrats: Medtronic vs. Becton, Dickinson & Company
Mar-06-17 09:30AM  The Zacks Analyst Blog Highlights: JPMorgan, Caterpillar, Broadcom, Mondelez and Becton Dickinson
Mar-03-17 11:14AM  Is Becton, Dickinson a Cure for a Sick Portfolio?
Mar-01-17 06:59AM  Pyxis ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care GlobeNewswire
Feb-22-17 08:00AM  BD To Present At Inaugural CECP CEO Investor Forum PR Newswire
06:59AM  BD Veritor System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests PR Newswire
Feb-21-17 06:59AM  BD Partnership Honored by U.S. Chamber of Commerce Foundation at the Health Means Business National Summit with Healthy10 Award PR Newswire
Feb-20-17 06:59AM  BD Demonstrates Synchronized Technology Platform at HIMSS17 PR Newswire
Feb-17-17 08:00AM  BD to Present at Investor Healthcare Conferences PR Newswire
Feb-16-17 08:15AM  Post Earnings Coverage as Becton, Dickinson and Co.'s Revenue Grew 6.1%; Adjusted EPS Gained 19.4% on Currency Neutral Basis Accesswire
06:59AM  BD Initiates New Industry Alliance To Combat Rising Opioid Crisis PR Newswire
Feb-14-17 09:32AM  Becton, Dickinson Launches BD Resolve Early Access Program
Feb-13-17 06:59AM  BD Announces Early Access Program for BD Resolve Single-Cell Analysis Platform PR Newswire
Feb-08-17 01:04PM  BECTON DICKINSON & CO Financials
Feb-06-17 01:42PM  ETFs with exposure to Becton, Dickinson & Co. : February 6, 2017
Feb-03-17 11:48AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q1, 2017 By the Numbers : February 3, 2017
Feb-02-17 01:06PM  BECTON DICKINSON & CO Files SEC form 10-Q, Quarterly Report
11:53AM  Edited Transcript of BDX earnings conference call or presentation 2-Feb-17 1:00pm GMT
10:14AM  Becton, Dickinson (BDX) Beats on Q1 Earnings & Revenues
08:01AM  Early movers: MRK, FB, BDX, CI, M, DLPH, EL & more at CNBC
08:00AM  Becton Dickinson and Co Earnings Call scheduled for 8:00 am ET today
07:43AM  Becton, Dickinson (BDX) Beats Q1 Earnings & Revenues
07:18AM  [$$] Becton Dickinson's Earnings Jump, and It Raises 2017 Outlook at The Wall Street Journal
07:18AM  Market Recon: The Market Has Run as Far as It Could on Hope
07:07AM  Q1 2017 Becton Dickinson and Co Earnings Release - Before Market Open
06:30AM  Becton Dickinson beats Street 1Q forecasts
06:00AM  BD Announces Results For 2017 First Fiscal Quarter PR Newswire
Feb-01-17 08:44AM  Medical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN
Jan-30-17 01:16PM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : December 09th, 2016 (record date) : By the numbers : January 30, 2017
10:13AM  Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?
Jan-26-17 11:18AM  BECTON DICKINSON & CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
06:59AM  New BD Institute For Medication Management Excellence Aims To Improve Patient Safety And Outcomes Through Collaboration PR Newswire
Jan-23-17 04:30PM  BD Board Declares Dividend PR Newswire
06:59AM  PleurX Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions PR Newswire
Jan-19-17 10:30AM  BECTON DICKINSON & CO Files SEC form 8-K, Entry into a Material Definitive Agreement
Jan-18-17 04:30PM  BD Announces Webcast of Annual Meeting of Shareholders PR Newswire
08:22AM  Becton, Dickinson Commercially Launches Precise WTA Kits
Jan-17-17 06:59AM  BD Launches Reagents to Simplify Single Cell Research PR Newswire
Jan-13-17 09:07AM  Inside Johnson & Johnsons Latest Dividend Payment
Jan-11-17 10:27AM  Becton, Dickinson & Co. Value Analysis (NYSE:BDX) : January 11, 2017
08:15AM  Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Accesswire
08:00AM  BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call PR Newswire
Jan-10-17 07:25AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : January 10, 2017
Jan-09-17 08:00AM  BD to Present at the 35th Annual J. P. Morgan Healthcare Conference PR Newswire
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
07:35AM  How Do Wall Street Analysts View Becton Dickinson?
07:04AM  Becton Dickinson downgraded by Raymond James
Jan-04-17 10:35AM  A Look at Becton Dickinsons Recent Stock Performance
09:05AM  Inside Becton Dickinsons Financial Guidance for 2017
08:01AM  10 Great All-Weather Stocks at Kiplinger
07:35AM  BDs Latest Dividend Payment and Capital Allocation Strategy
Jan-03-17 10:36AM  A Look at BDXs Recent Product Launches
09:06AM  Analyzing the BD Medical Segments Product Pipeline
07:36AM  BDs Medical Segment Performance and Growth Strategy
Jan-02-17 10:37AM  BD Lifesciencess Product Pipeline Could Boost Its Fiscal 2017 Growth
09:07AM  BD Lifesciencess Performance and Core Focus Areas
07:37AM  Becton Dickinsons Long-Term Growth Profile and Expectations
Dec-29-16 12:56PM  Unusual activity: BDX & JBLU
12:48PM  Farr: My top 10 stocks for 2017 at CNBC
Dec-23-16 11:45AM  The 10 Best Dividend Aristocrats for 2017 and Beyond
09:21AM  What Do Analysts Recommend for Baxter International?
Dec-20-16 07:35AM  Inside Edwards Lifesciences Financial Guidance for 2017
Dec-19-16 10:35AM  Understanding the Key Drivers of EWs Critical Care Business Growth
Dec-15-16 06:59AM  BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics PR Newswire
Dec-12-16 06:00AM  5 Investing Ideas From Top Dividend-Stock Fund Managers at Morningstar
Dec-09-16 04:41PM  BECTON DICKINSON & CO Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Dec-08-16 12:15PM  ETFs with exposure to Becton, Dickinson & Co. : December 8, 2016
Dec-06-16 01:00PM  These 3 Stocks Just Raised Their Dividends at Motley Fool
Dec-05-16 12:38PM  BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management PR Newswire
10:38AM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events
Dec-02-16 02:49PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-01-16 05:30PM  BD Announces Pricing of Tender Offers PR Newswire
05:05PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:11PM  BD Announces Early Tender Results and Upsizing of Maximum Tender Offers PR Newswire
06:59AM  BD Announces Adoption of Windows 10 'Internet of Things' for the Pyxis ES System PR Newswire
06:00AM  BD to Offer Euro-denominated Senior Unsecured Notes PR Newswire
Nov-30-16 09:22PM  Is Becton Dickinson and Co (BDX) A Good Stock To Buy Right Now? at Insider Monkey
04:02PM  Becton Dickinson Lifts Dividend by 11%
Nov-29-16 08:00AM  Upgrading Our Growth Forecast for Becton, Dickinson
Nov-28-16 12:51PM  Medtronic Registers Missed Revenue Estimates Yet Again, Earnings in-Line
11:56AM  ETFs with exposure to Becton, Dickinson & Co. : November 28, 2016
Nov-25-16 08:05AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: 2016 By the Numbers : November 25, 2016
Nov-23-16 11:53AM  BECTON DICKINSON & CO Files SEC form 10-K, Annual Report
08:30AM  BD to Present at the 28th Annual Piper Jaffray Healthcare Conference PR Newswire
07:13AM  Becton, Dickinson (BDX) Announces 10.6% Dividend Increase
Nov-22-16 11:04AM  Analyzing Strykers Latest Valuation
Nov-21-16 04:15PM  BD Board Increases Dividend PR Newswire
10:04AM  How Is Stryker Moving Forward with International Growth?
Nov-17-16 10:04AM  What Analysts Recommend for MDT ahead of Its Fiscal 2Q17 Results
08:05AM  Medtronics Fiscal 2Q17 Earnings Are Expected to Witness Growth
Nov-16-16 11:56PM  [$$] Caring for a growing world means halting mother and child deaths at Financial Times
06:04PM  Medtronics Revenue Is Estimated to Rise in Fiscal 2Q17
04:04PM  How Has Medtronics Stock Performed Recently?
12:03PM  Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR Newswire
Nov-15-16 08:15AM  Post Earnings Coverage as DENTSPLY Sales Surge 49% Accesswire
Nov-14-16 05:21PM  BD Announces 2016 Analyst Day And Webcast PR Newswire
12:56PM  ETFs with exposure to Becton, Dickinson & Co. : November 14, 2016
10:04AM  Portfolio Optimization Strategy Continues to Drive BDs Growth
Nov-11-16 06:04PM  What Were Becton Dickinsons 4Q16 Growth Drivers?
04:11PM  Whats behind Becton Dickinsons Strong Performance in 2016?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Option Exercise72.1244,3643,199,53266,458Feb 16 08:57 AM
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Sale180.0231,4645,664,24622,094Feb 16 08:57 AM
Conroy AlexandreExecutive Vice PresidentFeb 14Sale177.868,5001,511,81023,676Feb 15 11:31 AM
Gallagher John EVP, Corp Finance and TreasurerDec 15Sale168.821,793302,6942,796Dec 16 01:50 PM
Sichak StephenExecutive Vice PresidentDec 05Sale164.442,632432,8067,953Dec 06 01:48 PM
Sichak StephenExecutive Vice PresidentNov 04Option Exercise76.1818,2461,389,98026,892Nov 07 08:52 AM
Sichak StephenExecutive Vice PresidentNov 04Sale176.1010,3521,822,9878,646Nov 07 08:52 AM
Tharby Linda MExecutive Vice PresidentSep 06Option Exercise75.0120,2911,521,95722,146Sep 07 09:17 AM
Tharby Linda MExecutive Vice PresidentSep 06Sale177.2711,7042,074,8259,188Sep 07 09:17 AM
COHEN GARY MExecutive Vice PresidentAug 11Option Exercise76.6451,8333,972,481125,870Aug 12 09:40 AM
COHEN GARY MExecutive Vice PresidentAug 11Sale176.8129,3675,192,37974,037Aug 12 09:40 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Option Exercise76.183,500266,6306,758Jun 14 10:03 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Sale169.871,931328,0193,258Jun 14 10:03 AM
Shabshab NabilExecutive Vice PresidentJun 07Option Exercise74.219,055671,97811,363Jun 08 09:35 AM
Shabshab NabilExecutive Vice PresidentJun 07Sale168.755,080857,2506,700Jun 08 09:35 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Option Exercise76.2263,2004,817,38660,932May 18 09:37 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Sale166.2734,3735,715,19923,734May 18 09:37 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Option Exercise68.6064,5444,427,900207,225May 16 11:39 AM
Sichak StephenExecutive Vice PresidentMay 13Option Exercise72.1222,9151,652,63031,561May 16 10:56 AM
Sichak StephenExecutive Vice PresidentMay 13Sale166.4812,9952,163,4088,646May 16 10:56 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Sale166.1737,9336,303,327172,681May 16 11:39 AM
ORR JAMES FDirectorMay 10Sale167.661,368229,35923,045May 11 09:13 AM
Conroy AlexandreExecutive Vice PresidentMay 09Option Exercise71.8019,8111,422,36835,738May 10 02:26 PM
Lim James CExecutive Vice PresidentMay 09Sale165.605,257870,55912,556May 10 10:48 AM
Conroy AlexandreExecutive Vice PresidentMay 09Sale165.5811,2381,860,78825,611May 10 02:26 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Option Exercise74.3613,256985,65313,087May 09 04:52 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Sale163.907,2421,186,9645,789May 09 04:52 PM
RIMEL REBECCA WDirectorMay 06Sale163.69684111,9646,835May 09 04:02 PM
Hurwitz Jerome VExecutive Vice PresidentMay 06Sale163.583,878634,3633,027May 09 03:54 PM
Strahlman Ellen RSenior Vice PresidentMay 06Sale163.523,019493,6677,218May 09 03:44 PM
HUM Humana Inc. daily Stock Chart
HUM [NYSE]
Humana Inc.
IndexS&P 500 P/E52.71 EPS (ttm)4.05 Insider Own0.20% Shs Outstand144.28M Perf Week-2.62%
Market Cap30.78B Forward P/E17.91 EPS next Y11.91 Insider Trans-58.79% Shs Float143.77M Perf Month3.89%
Income614.00M PEG3.91 EPS next Q2.38 Inst Own98.30% Short Float5.46% Perf Quarter6.60%
Sales54.38B P/S0.57 EPS this Y-51.80% Inst Trans0.42% Short Ratio4.76 Perf Half Y22.61%
Book/sh71.45 P/B2.99 EPS next Y9.05% ROA2.30% Target Price224.21 Perf Year16.44%
Cash/sh26.87 P/C7.94 EPS next 5Y13.48% ROE5.70% 52W Range149.54 - 220.49 Perf YTD4.71%
Dividend1.60 P/FCF24.98 EPS past 5Y-13.60% ROI5.40% 52W High-3.12% Beta0.93
Dividend %0.75% Quick Ratio- Sales past 5Y8.10% Gross Margin- 52W Low42.84% ATR3.39
Employees51600 Current Ratio- Sales Q/Q-3.60% Oper. Margin3.20% RSI (14)52.57 Volatility1.63% 1.48%
OptionableYes Debt/Eq0.40 EPS Q/Q-499.90% Profit Margin1.10% Rel Volume0.31 Prev Close213.33
ShortableYes LT Debt/Eq0.35 EarningsFeb 08 BMO Payout28.20% Avg Volume1.65M Price213.60
Recom2.10 SMA20-0.50% SMA502.98% SMA20013.11% Volume216,913 Change0.13%
Jan-27-17Resumed BofA/Merrill Buy
Jan-24-17Downgrade Stifel Buy → Hold $214 → $210
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Downgrade Cantor Fitzgerald Buy → Hold
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Nov-10-16Upgrade JP Morgan Neutral → Overweight
Oct-13-16Reiterated RBC Capital Mkts Sector Perform $222 → $217
Jul-22-16Reiterated RBC Capital Mkts Outperform $220 → $224
Jul-22-16Reiterated FBR Capital Mkt Perform $220 → $170
Jul-18-16Upgrade Jefferies Hold → Buy $210
Jul-08-16Downgrade JP Morgan Overweight → Neutral $196 → $150
May-05-16Reiterated Stifel Buy $209 → $220
May-05-16Reiterated RBC Capital Mkts Sector Perform $209 → $220
Dec-16-15Initiated Credit Suisse Neutral
Nov-09-15Reiterated RBC Capital Mkts Sector Perform $223 → $215
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Reiterated RBC Capital Mkts Sector Perform $230 → $223
Jul-30-15Reiterated Barclays Equal Weight $180 → $193
Jul-07-15Reiterated FBR Capital Mkt Perform $150 → $230
Jul-07-15Downgrade Argus Buy → Hold
Mar-22-17 01:10PM  Humana places near top in national customer experience survey at bizjournals.com
11:46AM  Humana 2020 Bold Goal Progress Report: More Healthy Days Achieved, New Programs and Communities Planned Business Wire
11:40AM  Feds probe Humana on false claims to Medicare at bizjournals.com
07:15AM  Health care stocks under GOP plan
Mar-21-17 03:53PM  Health Insurance Lobby Backs Key Trumpcare Revisions at Forbes
03:30PM  ACA Repeal Faces Dire Prognosis
02:15PM  Humana, Continucare Team with Feeding South Florida to Address High Food Insecurity Business Wire
10:48AM  Humana Poised to Grow on Government Business, Strong Capital
Mar-20-17 04:30PM  Humana Inc. to Present at Oppenheimers 27th Annual Healthcare Conference Business Wire
Mar-19-17 09:31AM  U.S. Republicans working on Medicaid, tax credit changes-Ryan Reuters
Mar-18-17 01:00PM  Obamacare Repeal to Cut Deficit, but Greatly Expand Ranks of Uninsured
Mar-17-17 02:35PM  U.S. investigates four insurers over Medicare payments Reuters
01:06PM  U.S. probing insurers beyond UnitedHealth over Medicare charges Reuters
10:09AM  Why Improving Population Health Makes Financial Sense at Forbes
Mar-16-17 05:09PM  HUMANA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
04:30PM  Humana Completes Aggregate $1.0 Billion of Senior Notes Offering Business Wire
03:37PM  A.M. Best Assigns Issue Credit Ratings to Humana Inc.s Senior Unsecured Notes Business Wire
12:13PM  Obamacare Repeal Takes Another Step but GOP Showdown Looms
Mar-14-17 06:42PM  Trump's New Health Care Frontier
02:57PM  Humana selling bonds to raise $1 billion at bizjournals.com
12:12PM  Health Insurers in Bull Market Territory Despite Iffy American Health Care Act
06:04AM  HUMANA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-13-17 05:31PM  Humana Prices $1.0 Billion Debt Offering Business Wire
04:17PM  Pro: Hospitals will find themselves in 'very difficult ci...
03:48PM  Humana Is in a Sweet Spot
12:12PM  Humana Inc. -- Moody's rates Humana's senior notes Baa3; outlook stable at Moody's
09:00AM  Humana's Subsidiaries Receive Rating Action from A.M. Best
06:51AM  Street eyes battle for health care control
Mar-10-17 04:30PM  Humana Inc. to Present at the Barclays Global Healthcare Conference Business Wire
10:18AM  House leader: 'very difficult' to speed up end to Medicaid expansion Reuters
08:15AM  Response To GOP Healthcare Bill Ranges From Tepid Support To Outright Opposition
Mar-09-17 12:19PM  Trumpcare Won't Make Health Insurers Sick at The Wall Street Journal
11:09AM  Obamacare Repeal Heads to House Floor After 18 Hours of Debate
Mar-08-17 05:31PM  Humana CEO Bruce Broussard's pay nearly doubled in 2016 at bizjournals.com
04:01PM  A.M. Best Removes From Under Review With Positive Implications and Affirms Credit Ratings of Humana Inc. and Its Subsidiaries Business Wire
01:40PM  Democrats fight Trump-backed U.S. healthcare plan, Ryan defends it Reuters
01:07PM  The Biggest Puzzle About Paul Ryan's ObamaCare Repeal
10:49AM  Health Insurers Hit 52-Week Highs: What's Behind the Rise?
10:00AM  Humana Recognized as Health Care Industry Leader for Corporate Social Responsibility Commitment Business Wire
09:40AM  House panels to launch fight in Congress over Obamacare replacement Reuters
09:25AM  AMA Says Trumpcare Is 'Critically Flawed' at Forbes
Mar-07-17 11:17PM  Stocks: Ready for Trump rally rebound or third straight down day and bigger retreat from Dow 21K? at bizjournals.com
05:50PM  Conservatives rebel against Trump-backed Republican healthcare plan Reuters
05:35PM  Daniel Loeb Buys JPMorgan, Time Warner, Bank of America
05:07PM  3 large-cap buys to play strength in health care: Ross
04:22PM  Stocks Slip Into A Red Finish As RV Makers Break Camp, Data Storage Soars
04:18PM  The Hot Stock: Humana Gains 2.4% at Barrons.com
03:58PM  Biotech beat up?
01:09PM  Today's charts: Aetna, Humana, Cigna and Anthem on the move after new GOP health care bill
11:00AM  Humana and Quartet Team Up to Deliver Integrated Mental Health Care to New Orleans Residents Business Wire
07:54AM  Early movers: DKS, MIK, NAV, PFE, AET, CSX, & more at CNBC
06:31AM  What's working: Health care stocks after Obamacare
Mar-06-17 02:03PM  What if there's no affordable insurance to buy?
Mar-05-17 09:02AM  Rift Widens, Fractures Grow Among Republicans On Obamacare at Forbes
Mar-03-17 02:12PM  Humana, Inc. : HUM-US: Dividend Analysis : January 12th, 2017 (record date) : By the numbers : March 3, 2017
Mar-02-17 12:35PM  Humana cuts jobs but offers few details at bizjournals.com
Mar-01-17 04:42PM  Connecticut says will not drop opposition to Anthem/Cigna deal Reuters
01:19PM  Humana Set to Lay off an Unspecified Amount of Employees
09:22AM  Humana (HUM) Includes Methodist Healthcare in its Network
08:54AM  HUMANA INC Files SEC form 8-K, Regulation FD Disclosure
Feb-28-17 05:52PM  Tenet Shares Drop as First Quarter Guidance Sinks
02:22PM  Methodist Healthcare Enters into New Agreement with Humana Business Wire
02:04PM  Tenet Healthcare: 'The Single Most Frustrating Stock, Ever' at Barrons.com
Feb-27-17 04:34PM  HUMANA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
02:34PM  Trump seeks help of insurers to smooth Obamacare transition Reuters
11:32AM  Trump meets insurers, promises catastrophic year for Obamacare Reuters
10:00AM  Humana Uncovers Wellness Trends to Help Employers Create a Happier, Healthier Workplace Business Wire
09:02AM  Trump, insurers to huddle on Obamacare | Sharp boost planned for military spending at MarketWatch
01:48AM  When Patients Share Stories, Health Insights Emerge at The Wall Street Journal
01:48AM  [$$] Health Insurers Hope for Nothing at The Wall Street Journal
Feb-26-17 04:09PM  5 Trade Ideas for Monday: Alcoa, CME, Humana, Molson and Whole Foods
01:14PM  [$$] Health Insurers Hope for Nothing at The Wall Street Journal
Feb-24-17 02:09PM  Affordable Care Act Replacement Bill Leaked
Feb-23-17 05:04PM  5 Things Republicans Want To Change About Obamacare But Might Not Be Able To
Feb-22-17 04:41PM  Humana Inc (HUM): Whats Next After The Failed Merger? at Insider Monkey
01:04PM  HUMANA INC Financials
11:36AM  Trump, House Republicans Seek Delay In Healthcare Ruling - Because They're Afraid They'll Win
09:59AM  Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem?
08:50AM  Health insurer Aetna to spend $3.3B buying back stock
07:35AM  Humana execs sold $66 million in company stock yesterday at bizjournals.com
Feb-21-17 04:30PM  10 Biggest HMOs in USA at Insider Monkey
Feb-18-17 01:25AM  [$$] Baird Sticks With Its Wal-Mart Rating and Target Price at Barrons.com
Feb-17-17 04:52PM  Aetna Shares Bounce Back After Close
04:27PM  UnitedHealth, Health Insurers Fall As DOJ Joins Whistleblower Suit
04:11PM  Aetna fattens shareholder payout after Humana deal fails
03:34PM  [$$] Aetna Doubles Dividend, Boosts Buyback Plans at The Wall Street Journal
03:31PM  Moody's Jumps into Action as Aetna-Humana Deal Fails
12:22PM  Today's charts: UnitedHealth, Humana, Aetna, Anthem shares fall
08:43AM  HUMANA INC Files SEC form 10-K, Annual Report
06:45AM  What does the Humana departure from ACA exchanges mean for Obamacare? at bizjournals.com
Feb-16-17 09:30PM  New Study: Aging Americans Snubbed in Best Picture Films Business Wire
05:41PM  Aetna Inc. -- Moody's affirms Aetna's ratings and confirms Humana's ratings following cancellation of planned merger at Moody's
04:59PM  What Blocked Mergers Mean for Managed Care
03:25PM  What Humana leaving ACA exchanges means for Memphis at bizjournals.com
02:00PM  Caravan Health Enters into Value-Based Agreement with Humana in Kansas, Missouri, Arkansas and Oklahoma Business Wire
11:14AM  Insurance Megadealers Need to Get Creative at Bloomberg
08:17AM  Aetna CEO: Why the Merger With Humana Fell Apart at MarketWatch
05:57AM  Aetna CEO on Obamacare's 'Death Spiral' at MarketWatch
Feb-15-17 09:02PM  No Valentine's Day love: 2 big insurance deals appear off
04:40PM  Fossil and AIG slump, Procter & Gamble and Fortress jump
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment offers commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only products, and health and wellness products to employer groups. It also provides military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2016, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.0 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BILNEY JODY LSVP & Chief Consumer OfficerMar 21Sale213.804,348929,62013,578Mar 22 01:01 PM
KAY CHRISTOPHER ESVP & Chief Innovation OfficerMar 17Option Exercise0.006,13406,837Mar 21 12:09 PM
MURRAY JAMES EEVP & COOMar 06Option Exercise164.6510,8461,785,74045,635Mar 07 04:06 PM
MURRAY JAMES EEVP & COOMar 06Sale213.6520,3054,338,2300Mar 07 04:06 PM
MURRAY JAMES EEVP & COOMar 06Sale213.5510,8462,316,14834,789Mar 07 04:06 PM
Dunbar Webster RoyDirectorMar 03Sale213.123,000639,3601,166Mar 06 04:55 PM
Zipperle Cynthia HVice President, CAO,ControllerMar 03Sale213.371,885402,2063,736Mar 06 04:48 PM
PETERSON MARISSA TDirectorFeb 27Sale207.523,305685,863761Mar 01 04:18 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Option Exercise164.654,971818,45014,258Feb 27 02:53 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Sale204.814,9711,018,1029,287Feb 27 02:53 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 22Option Exercise119.7314,6251,751,00537,157Feb 22 07:59 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 22Sale205.2426,8945,519,6179,289Feb 22 07:59 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerFeb 22Sale205.204,020824,9208,966Feb 22 06:53 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerFeb 22Sale205.734,832994,0908,931Feb 22 06:47 PM
MURRAY JAMES EEVP & COOFeb 22Sale204.699,5231,949,21659,932Feb 22 09:06 PM
MURRAY JAMES EEVP & COOFeb 21Option Exercise132.1046,1676,098,840115,131Feb 22 09:06 PM
BROUSSARD BRUCE DPresident & CEOFeb 21Option Exercise94.6467,6216,399,648197,316Feb 22 06:43 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 21Option Exercise44.964,213189,3959,834Feb 22 07:15 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 21Option Exercise102.1697899,90823,589Feb 22 07:18 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 21Option Exercise102.165,029513,73742,650Feb 22 07:21 PM
Christopher M TodoroffSr. VP and General CounselFeb 21Option Exercise95.0119,9471,895,18638,978Feb 22 08:09 PM
Christopher M TodoroffSr. VP and General CounselFeb 21Sale205.3324,1404,956,55014,351Feb 22 08:09 PM
BILNEY JODY LSVP & Chief Consumer OfficerFeb 21Sale204.726,0871,246,13817,926Feb 22 08:05 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 21Sale204.9425,5295,231,82416,634Feb 22 07:21 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 21Sale205.2813,4522,761,4179,650Feb 22 07:18 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 21Sale204.674,213862,2835,621Feb 22 07:15 PM
BROUSSARD BRUCE DPresident & CEOFeb 21Sale205.23104,25621,396,77292,086Feb 22 06:43 PM
JONES DAVID A JR/KYDirectorFeb 21Sale205.0427,0005,536,16927,050Feb 23 11:58 AM
MURRAY JAMES EEVP & COOFeb 21Sale205.5042,7168,778,1460Feb 22 09:06 PM
MURRAY JAMES EEVP & COOFeb 21Sale205.2070,33214,431,98234,789Feb 22 09:06 PM
Christopher M TodoroffSr. VP and General CounselFeb 18Option Exercise0.0010,651023,675Feb 22 08:09 PM
BILNEY JODY LSVP & Chief Consumer OfficerFeb 18Option Exercise0.0010,651028,577Feb 22 08:05 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 18Option Exercise0.007,889025,734Feb 22 07:59 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 18Option Exercise0.0010,651042,169Feb 22 07:21 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 18Option Exercise0.005,128024,499Feb 22 07:18 PM
Zipperle Cynthia HVice President, CAO,ControllerFeb 18Option Exercise0.002,58406,542Feb 22 07:15 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerFeb 18Option Exercise0.007,889016,855Feb 22 06:53 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerFeb 18Option Exercise0.0010,651018,439Feb 22 06:47 PM
BROUSSARD BRUCE DPresident & CEOFeb 18Option Exercise0.0053,2570155,108Feb 22 06:43 PM
MURRAY JAMES EEVP & COOFeb 18Option Exercise0.0017,357076,798Feb 22 09:06 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerJan 06Option Exercise0.0014,827015,542Jan 10 01:48 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsDec 22Option Exercise123.7611,7491,454,10328,432Dec 23 01:11 PM